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ABSTRACT 
Investigation of Autonomic Dysfunction as a Potential Pathogenic 
Mechanism Underlying the Association between Sleep and Childhood Obesity 
Denise Christina Jarrin 
The prevalence of childhood obesity has increased almost threefold over the past 
two decades. Shorter sleep duration has been linked to greater body mass index and 
obesity, both cross-sectionally and in prospective longitudinal studies. Sleep loss has 
been found to be related to autonomic dysfunction. As well, obese youth exhibit markers 
of autonomic dysfunction characterized by reduced heart-rate variability (HRV). The 
aim of the present study was to investigate whether autonomic dysfunction is a 
pathogenic mechanism that mediates the association between shorter sleep duration and 
childhood obesity. 
Participants included 122 youth (50.8% females) aged 8-17 years (M=12.79, 
SD=2.19). Youth wore an ambulatory monitor for 24-hours to assess HRV derived from 
continuous ECG recordings. They also completed an in-home polysomnograph sleep 
study (n=57) to assess objective sleep measures (e.g., fragmented sleep, sleep efficiency, 
and time spent in REM sleep). Subjective sleep measures (e.g., sleep duration, daytime 
sleepiness, and sleep quality) were obtained by child- and parent-report on validated 
questionnaires. 
Shorter sleep duration and poorer sleep quality were found to be associated with 
greater adiposity. Autonomic dysfunction, as characterized by reduced HRV and 
parasympathetic activity also was found to be associated with greater adiposity. 
However, autonomic dysfunction was not found to mediate the association between sleep 
and obesity. Future research should aim to better understand the role of autonomic 
iii 
dysfunction and its other indices (e.g., blood pressure), as well as hormonal and 
endocrine function across the course of sleep, as potential pathogenic mechanisms 
underlying the association between sleep and obesity in youth. 
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INTRODUCTION 
The Childhood Obesity Epidemic 
Childhood overweight and obesity has been identified as an international 
epidemic (Ebbeling, Pawlak, & Ludwig, 2002; Hossain, Kawar, & El Nahas, 2007). The 
proportion of overweight and obese youth has been rising in both developed and 
developing countries at an astonishing rate (Wang & Lobstein, 2006). In the United 
States, one in every four youth aged 6-19 years old is overweight and 11% are obese 
(Nicklas, Baranowski, Cullen, & Berenson, 2001). 
In Canada, using data from two nationally representative surveys, the prevalence 
of overweight and obesity increased substantially from 1981 to 1996 from 11-33% and 2-
10%, respectively (Tremblay, Katzmarzyk, & Willms, 2002). Even more alarming, 
youth are becoming overweight and obese at a faster rate than adults (Flegal & Troiano, 
2000; Tremblay et al., 2002; Willms, Tremblay, & Katzmarzyk, 2003), and as a result, 
adult-obesity related diseases are now being diagnosed in youth. Further, there is a 
tendency for obese children to remain obese adults (Whitaker, Wright, Pepe, Seidel, & 
Dietz, 1997) with evidence supporting the idea of childhood obesity tracking (persistence 
of relative rankings) into adulthood. As example, childhood body mass index at ages 2-
17 was associated with adult BMI 17.5 years later (Freedman, et al., 2005). These 
findings suggest that heavy children remain heavy as adults compared to thinner children. 
Because obesity and its co-morbidities during childhood track into adulthood, 
there is an unprecedented impending threat of the economic burden on national health 
care costs. In the United States, ~300,000 deaths per year and over 30% of pediatric 
hospitalizations have been attributed to obesity and obesity-related co-morbidities 
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(Allison, Fontaine, Manson, Stevens, & Vanltallie, 1999; Wang & Dietz, 2002). Health 
costs associated with obesity have tripled from 1971-81 to 1997-99, representing more 
than $127 million annually in the United States (Wang & Dietz, 2002). 
Childhood Obesity and its Health Complications 
Overweight and obesity confer risk to many health conditions such as chronic 
diseases, disability, and even premature death (Must & Anderson, 2000). Overweight 
and obese youth already show precursors for cardiovascular diseases, hypertension, 
increased plasma insulin concentrations, insulin resistance, impaired glucose tolerance 
(Freedman, Dietz, Srinivasan, & Berenson, 1999), and chronic inflammation (Ferguson, 
Gutin, Owens, Litaker, Tracy, & Allison, 1998; Ford, Galuska, Gillespie, Will, Giles, & 
Dietz, 2001). Excess weight has also been associated with Parkinson's disease, 
polycystic ovary disorder, gallbladder disease, asthma, sleep apnea, arthritis (knee and 
ankle) and orthopedic problems (Goulding, Jones, Taylor, Williams, & Manning, 2001; 
Must & Strauss, 1999; Wang & Dietz, 2002). 
Although obesity is a risk factor associated with many health problems, risk 
depends on the location of excess adipose tissue. Central adiposity, an excess of adipose 
tissue mainly around the abdomen, and visceral obesity, an excess of adipose tissue 
inside the space within the intestines, stomach, and liver, are both associated with 
increased risk of impaired glucose tolerance (Blaha, Gebretsadik, Shintani, & Elasy, 
2008), insulin resistance, type 2 diabetes (Caballero, 2003), atherogenic lipoprotein 
profiles, and cardiovascular diseases in youth (Flodmark, Sveger, & Nilsson-Ehle, 1994). 
Interestingly, fat distributed in the lower portion of the body (i.e., hips, thighs, and 
buttocks) has lower health risks than central adiposity (Hartz et al, 1990). In addition to 
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physical health risks, psychological and mental disorders such as depression, low self-
esteem, and social stigmatization are present in overweight and obese youth (Dietz, 1998; 
French, Story, & Perry, 1995; Must & Strauss, 1999). Thus, the dramatic rise in the 
prevalence of obesity and its related co-morbidities represents a severe threat to public 
health. 
Measuring Obesity 
Multiple techniques exist to accurately assess body composition and fat 
distribution. Considered the gold standard, dual energy X-ray absorptiometry (DEXA) 
scans estimate the distribution and the total amount of lean and fat mass as well as 
percent body fat (Mazess, Barden, Bisek, & Hanson, 1990). Underwater weighing 
measures body fat as the calculated difference between in- and out- of water 
measurements. While both of these techniques are reliable and valid, they are expensive 
procedures requiring specialized equipment, qualified personnel, and cumbersome 
procedures (Mazess et al., 1990). Bioelectrical impedance analysis applies a low electric 
current that flows through conductive (e.g., muscle, organs, body water) and non-
conductive body tissue (e.g., fat) to assess the volume of lean and fat mass. It is a safe, 
noninvasive, and a validated method frequently used to assess percent body fat (Mazess 
etal , 1990). 
Skinfold thickness and waist circumference are anthropometric measurements 
used to estimate body fat distribution. Skinfold thickness involves more invasive 
procedures that measure the amount of adipose tissue under the skin using standardized 
calipers by trained personnel. Waist circumference is less invasive and is considered a 
reliable indicator of central adiposity in youth (Blaha et al., 2008; de Ridder et al , 1992; 
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Fox, Peters, Armstrong, Sharpe, & Bell, 1993; Goran, Gower, Treuth, & Nagy, 1998; 
Lee, Song, & Sung, 2008; Taylor, Jones, Williams, & Goulding, 2000; Wells & Fewtrell, 
2006). Waist circumference has high sensitivity (89%; correctly identifies youth with 
central obesity) and specificity (94%; correctly identifies youth without central obesity), 
compared to DEXA scans (Taylor et al., 2000). 
Body mass index (BMI) is frequently used in epidemiological studies because it is 
an easy, noninvasive, and reliable indicator of overweight and obesity in youth (Barlow 
& Dietz, 1998; Kopelman, 2000). BMI is correlated with direct measures of fatness and 
it is validated against DEXA scans, underwater weighing (Freedman et al., 2005; Mei et 
al., 2002; Pietrobelli et al., 1998), waist circumference (Blaha et al., 2008; Sawa et al., 
2000), and skinfold thickness (Morrison, Barton, Biro, Daniels, & Sprecher, 1999; 
Morrison, Sprecher, Barton, Waclawiw, & Daniels, 1999). However, the usefulness of 
BMI values are limited as they do not indicate distribution of body fat or differentiate 
between fat and fat-free mass (Wells & Fewtrell, 2006). 
Defining Obesity in Youth 
Defining obesity in youth is challenging because body fatness depends on several 
factors, including sex, racial/ethnic backgrounds, age, and growth patterns (Rosner, 
Prineas, Loggie, & Daniels, 1998). In general, boys tend to show greater overweight and 
obesity prevalence rates than girls (Tremblay et al., 2002). Native American, Black, and 
Latin children are heavier and have greater abdominal and trunk adiposity than Caucasian 
children (Afghani & Goran, 2006). During childhood, growth patterns are similar 
between boys and girls; however, during adolescence, girls tend to gain weight composed 
mainly of fat, whereas boys gain fat-free mass (Maynard et al., 2001). 
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To account for the timing of growth patterns for boys and girls, the Centers for 
Disease Control and Prevention (CDC) developed cutoff values for age- and sex-specific 
BMI distributions (2000). Based on national surveys of American children, the CDC 
BMI growth charts reflect body composition and include percentile distributions for the 
weight status of children aged 2-18 years. The most recent growth charts (CDC, 2000) 
are considered the best reference on the established criteria for tracking growth patterns 
in youth (Kuczmarski et al., 2000), even though the curves are in part based on data from 
1963-1995. BMI categories for youth include underweight (<5 percentile), healthy 
weight (5th to 85th percentile), overweight (>85th to <95th percentile), and obese (^^ 
percentile; CDC, 2000). 
The International Obesity Task Force (IOTF) definitions are based on other BMI 
cutoff points developed as a screening tool to detect childhood obesity. They are based 
on the World Health Organization BMI categories used to identify overweight (BMI 
>24.9-29.9) and obese (BMI >30) adults (Kuczmarski, Carroll, Flegal, & Troiano, 1997). 
These adult cutoff points are linked with age- and sex- specific BMI cutoff points specific 
to childhood overweight and obesity (Cole, Bellizzi, Flegal, & Dietz, 2000). Both the 
CDC and IOTF criteria are the most commonly used BMI cutoff points used to assess 
body fatness in youth. 
Association between Childhood Obesity and Sleep: Cross-Sectional Studies 
Intriguingly, mirroring the increased trends of overweight and obesity, total sleep 
duration and sleep quality have decreased among children and adolescents across three 
decades (Iglowstein, Jenni, Molinari, & Largo, 2003). Recently, several cross-sectional 
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studies have found significant associations between decreased sleep duration and 
excessive weight status among youth. 
von Kries and colleagues (2002) found a dose-dependent relation between 
increased adiposity (measured by BMI with height and weight and percent body fat with 
bioelectrical analyses) and reduced sleep duration in more than 6800 children aged 5-6 
years. Children sleeping >11.5 hrs had the lowest risk of having excessive body fat and 
of being overweight/obese compared to children sleeping <10 hrs, even after adjusting 
for several confounders including parental obesity, socioeconomic status, birth weight, 
weight gain, time spent watching television, and snacking. Also, percent body fat in 
children sleeping <10 hrs per night doubled from 7-15.6%, compared to children sleeping 
>11.5 hrs each night. 
Similarly, in the Quebec en Forme Project (2006), Chaput and colleagues found 
that in 422 children aged 5-10 years, decreased sleep duration was significantly 
associated with greater body weight, waist circumference, and BMI in boys. Among 
girls, similar associations were observed, although the correlations did not reach 
significance. Even after controlling for potential risk factors associated with obesity 
(e.g., age, sex, parental obesity, parental education, family income, single parenthood, 
physical activity, breastfeeding time, and time spent watching television) results yielded 
that children sleeping only 8-10 hrs had significantly greater odds of being 
overweight/obese, compared to children sleeping >12 hrs each night. These findings 
have been replicated in multiple studies in toddlers and in children (cf. Gibson, Lambert, 
& Neate, 2004; Hui, Nelson, Yu, & Fok, 2003; Kagamimori et al , 1999; Padez, Mourao, 
Moreria, & Rosado, 2005; Sekine et al , 2002). 
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This relationship has also been reported among adolescents. Recently, Seicean 
and colleagues (2007) asked 529 adolescents aged 14-18 years to self report the number 
of hours they typically sleep and to estimate their height and weight to calculate BMI. A 
dose-response relationship between being overweight/obese and sleep duration was 
found. Even after adjusting for sex, age, irregular eating, health status, and caffeine 
intake, youth who reported sleeping <5 average had greater odds of being overweight, 
than youth who reported sleeping >8 hours per night. Even in cross-sectional studies 
using objective measures of sleep duration (versus self-report), the link between reduced 
sleep duration and obesity has been observed. 
In the Heartfelt Study, Gupta and colleagues (2002) had 383 adolescents aged 11-
16 years wear wrist actigraphs for 24-hours to continuously measure total sleep duration. 
Youth who slept fewer hours were heavier (greater BMI and percent body fat) than those 
who slept longer hours, even after adjusting for sex, age, race, and pubertal status. In 
fact, for every additional hour of sleep lost, the likelihood of being obese increased by 
80%. In another study, Beebe and colleagues (2007) compared sleep of overweight and 
healthy youth between the ages of 10-17 years using multiple indices of sleep. Based on 
wrist actigraphy, overweight youth slept 38 minutes less, had poorer sleep quality and 
less continuous, more fragmented sleep compared to healthy controls. No significant 
differences between groups were observed with overnight polysomnograph (PSG). 
Overweight youth complained more about daytime sleepiness and reported sleeping -30 
minutes less on school nights and their parents perceived them as displaying more sleep 
problems (e.g., bedtime resistance, daytime sleepiness) compared to healthy controls. 
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Thus, heavier youth obtained less sleep, of poorer quality, and exhibited and complained 
of more sleep-related problems compared to their lean counterparts. 
Collectively, these cross-sectional studies provided robust evidence suggesting 
that heavier youth sleep fewer hours than lean youth. Using multiple measures of 
adiposity (e.g., BMI, waist circumference, percent body fat) and sleep (e.g., actigraphy, 
PSG; Beebe et al., 2007; Gupta et al., 2002), a dose-response relation between short sleep 
duration and increased weight status was consistently observed in both children and 
adolescents. Additionally, although sex differences were reported in some studies 
(Eisenmann, Ekkekakis, & Holmes, 2006; Knutson, 2005), these results were inconsistent 
and pubertal status was not objectively measured, thus confounding the results. 
In summary, multiple cross-sectional studies present strong evidence that 
corroborates the association between short sleep duration and childhood 
overweight/obesity. Unfortunately, it is impossible to identify a causal relationship and 
determine whether short sleep duration precedes the development of obesity or vice versa 
from cross-sectional studies. However, results from prospective studies provide evidence 
for a possible causal mechanism and suggest that short sleep duration predicts future 
development of overweight/obesity. Prospective studies examining the association 
between sleep duration and obesity are presented in the next section. 
Association between Childhood Obesity and Sleep: Prospective Studies 
Several studies have demonstrated a longitudinal relationship between the amount 
of sleep obtained and future development of obesity in youth (cf. Agras et al., 2004; 
Lumeng et al., 2007; Seicean, 2007). Reilly and colleagues (2005) followed 8234 
children from birth to 7 years, and although sleep duration was not the main variable 
8 
being investigated, a dose-response relation between reduced sleep duration at age 30 
months and obesity at age 7 years was found. Compared to toddlers sleeping >12.5 hrs 
per day, toddlers sleeping <10.5 hrs had the highest odds ratio of becoming obese 
compared to toddlers sleeping 10.5-10.9 hrs or 11-11.9 hrs, even after controlling for 
numerous covariates (i.e., sex, socioeconomic status, birth weight, physical activity, and 
energy intake at 36 months). 
Lumeng and colleagues (2007) examined sleep duration assessed by parental 
report when their child was 9 years and again at age 12 years. After controlling for sex, 
race, maternal education, change in sleep duration, and baseline BMI, reduced sleep 
duration at age 9 predicted greater BMI and overweight status at age 12. In fact 9-year 
olds were approximately 40% less likely to be overweight three years later based on 
every additional one hour of sleep they obtained. More importantly, even after 
controlling for changes in sleeping patterns during the transition from childhood to 
adolescence (Carskadon, Acebo, & Jenni, 2004), reduced sleep duration was 
independently linked to increased risk of future overweight status three years later. 
Snell and colleagues (2007) found children who had short sleep duration, later 
bedtimes, and/or earlier wake times at age 3 had higher BMI values and greater risk of 
being overweight five years later, even after controlling for baseline BMI and overweight 
status. In fact, sleep duration at baseline accounted for 23.8% of the variance in BMI and 
12.8% of the variance in overweight at follow-up. 
Similar results have been reported for infant's sleep duration and future weight 
gain. Shorter sleep duration at 6 and 24 months predicted greater skinfold thickness and 
overweight status in children at 36 months (Taveras et al., 2008), even after taking into 
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account several covariates. In addition, frequent sleep problems such as irregular 
sleeping habits, trouble initiating sleep, and disruptive sleep during the first few years of 
life were associated with an increased risk of being overweight and almost a two-fold 
increase of being obese at age 21 (Al Mamun et al., 2007). Thus, these longitudinal 
results support the causal nature of the relationship between reduced sleep duration 
preceding the development of obesity, even after controlling for important covariates. 
In a recent meta-analysis, Chen and colleagues (2008) examined the association 
between sleep duration and childhood obesity from twelve cross-sectional, three 
prospective, and two case-control studies. Across all studies, short sleep duration was 
associated with an increased risk for overweight/obesity for the entire general pediatric 
sample. For every hour of sleep obtained the probability of increased weight status 
decreased by roughly 9%. Sex differences were also examined; boys with short sleep 
duration had a greater risk of being overweight/obese than girls. However, no significant 
sex differences were found based on age and the studies did not consistently assess or 
control for pubertal status. Overall, this meta-analysis found a robust link between short 
sleep duration and increased weight status in youth. 
In summary, these prospective studies had strong methodological designs, which 
included multiple time assessments, the use of validated sleep questionnaires, and large 
sample sizes. Therefore, the notion that short sleep duration precedes weight gain is 
supported by both cross-sectional and prospective studies. This relation does not appear 
short-lived, but rather encompasses significant predictive power for future risk of obesity. 
Evidence suggests that short sleep duration during childhood, especially during preschool 
years, may be a critical risk factor with long-term consequences for the development of 
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obesity several years later. Unfortunately, the mechanisms underlying the association 
between sleep duration and obesity have not been fully elucidated. Because sleep is 
highly integrated with several networks in the body it has been suggested that there exist 
several potential mediators underlying the link between sleep and obesity. 
Potential Underlying Mechanisms 
Some researchers have postulated that reduced sleep duration may be considered 
a stressor that leads to adverse modifications in several critical systems in the body. The 
allostatic load theory refers to the wear and tear on the body and has been used to explain 
the pathophysiological mechanisms underlying the relation between short sleep duration 
and weight gain (McEwen, 2006). During normal sleep and wake cycles, the 
neuroendocrine, immune, and autonomic nervous system adapt and change to maintain 
homeostasis or allostasis (McEwen, 2002). These systems reflect a highly 
interconnected network and even small changes in production (e.g., hormones) can cause 
damage to the entire network. Therefore, when sleep is reduced, changes within the 
network occur and an allostatic overload develops (McEwen, 2006). If this allostatic 
overload is prolonged (e.g., chronic sleep loss), it can have harmful behavioural, 
neurobiologic, and physiologic consequences (McEwen, 2006). 
Sleep is recognized as an important regulator of hypothalamic-pituitary processes 
that affect food consumption, energy expenditure, and metabolism; all of which are 
associated with circadian rhythms (Laposky, Bass, Kohsaka, & Turek, 2008). Following 
acute and chronic sleep restriction, animals show increased basal corticosterone and 
adrenocorticotropic hormone concentrations (Meerlo et al., 2002) and adult humans show 
increased basal adrenocorticotropin and Cortisol concentrations (Steiger, 2002). The 
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regulation and variation of Cortisol concentrations are altered, with significantly greater 
Cortisol levels in the morning (Capaldi et al., 2005), late afternoon, and early evening 
having been reported following acute and chronic sleep loss (Spiegel, Knutson, Leproult, 
Tasali, & Van Cauter, 2005). In addition, increased basal Cortisol secretion is associated 
with longer sleep latency, poor perceived sleep quality, more fragmented sleep, and poor 
sleep patterns in adults (Vgontzas et al., 2003) and children (Hatzinger et al., 2007). 
Glucose metabolism is also found to be influenced by sleep loss, with short 
sleepers (< 5 hrs) having an increased risk of diabetes up to 22 years later, compared to 
long sleepers (7-8 hrs; Ayas et al., 2003; Nilsson et al., 2004). Experimental studies 
show that sleep restriction leads to significantly elevated glucose concentrations and 
reduced insulin sensitivity, even after controlling for food intake (Spiegel et al., 2005). In 
fact, the values of glucose concentrations obtained during sleep restriction were similar to 
those observed in individuals with impaired glucose tolerance and patients with type 2 
diabetes. Further, loss of slow wave sleep is associated with reduced insulin sensitivity, 
reduced compensatory insulin secretion, and an overall poor glucose homeostasis in 
healthy young men (Tasali et al., 2008). 
Sleep also influences metabolic hormones associated with appetite. Two of many 
appetite-regulating hormones include the appetite-stimulating ghrelin and appetite-
inhibiting leptin. Ghrelin is a hormone that is mainly synthesized in the stomach. It 
stimulates caloric intake, down regulates energy expenditure, and conserves fat in the 
body (Horvath, Diano, Sotonyo, Herman, & Tschop, 2001). In humans, ghrelin levels 
increase before food intake (Wren et al., 2001) decrease after meals, and increase again 
approximately 1.5-2 hours after eating, in parallel with feelings of hunger (Shinya et al., 
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2005). Leptin is a hormone that is synthesized in adipose tissue. It is released into the 
blood and regulates food intake and energy metabolism (Sunter, O'Shea, & Bloom, 
1997). Fasting and energy restriction decrease leptin levels and increase sensations of 
hunger (Keim, Stern, & Havel, 1998; Tritos & Mantzoros, 1997). Eating results in 
elevated levels of leptin (Tritos & Mantzoros, 1997), inducing satiety, decreasing 
appetite, and increasing energy expenditure (Campfield, Smith, Guisez, Devos, & Burn, 
1995; Pelleymounter et al., 1995). 
Circulating leptin and ghrelin levels show opposing patterns with leptin secretion 
increasing approximately 50% during the night compared to the day (Sinha, Sturis et al., 
1996; Tritos & Mantzoros, 1997) and ghrelin levels decreasing during the second half of 
the sleep period (Dzaja et al., 2004; Sinha, Ohannesian, et al., 1996). However, short 
sleepers (5 hrs) showed 18% lower leptin levels and 15% higher ghrelin levels compared 
to long sleepers (8 hrs) the following morning, even after controlling for BMI (Taheri, 
Lin, Austin, Young, & Mignot, 2004). Following acute and chronic sleep deprivation, 
Spiegel and colleagues (2004) found young healthy men showed an earlier acrophase of 
leptin (by 2 hrs), a 26% reduction in the nocturnal acrophase of leptin, and an overall 
19% decrease in mean leptin concentrations, irrespective of caloric intake, physical 
activity, and BMI. Further, hunger increased by 24% and appetite for high caloric-dense 
foods such as sweets, salty snacks, and starchy foods increased by 23%. Short sleep 
duration is associated with unhealthy eating behaviours (e.g., reduced intake of 
vegetables, irregular eating habits, snacking between meals, and increased food 
seasoning; Imaki, Hatanaka, Ogawa, Yoshida, & Tanada, 2002; Ohida, Kamal, 
Uchiyama, et al., 2001). This suggests that short sleep duration adversely affects the 
13 
appetite-regulating hormones which are interestingly also associated with changes in 
perceived hunger and appetite. 
Numerous studies have provided evidence demonstrating that sleep loss adversely 
influences a variety of physiological processes important in metabolism and hunger 
regulation (Spiegel, Leproult, & Van Cauter, 1999). Therefore, sleep loss, through 
multiple pathophysiological alterations, offers a plausible biological link as an indirect, 
yet vital role in the development and maintenance of obesity. However, given that 
autonomic dysfunction is related with adverse physiological correlates which in turn 
confer risk to obesity, autonomic dysfunction has been proposed as one potential 
mediator elucidating the association between sleep and the etiology of obesity. 
Autonomic Functioning 
The autonomic nervous system (ANS) is the neural part of the nervous system 
which is responsible for homeostasis in the body, vital organs (e.g., lungs, kidneys), 
endocrine and exocrine glands, as well as the cardiovascular system (Furness, 2006). The 
ANS is comprised of two branches: the parasympathetic nervous system (PNS) and the 
sympathetic nervous system (SNS). The PNS and SNS work in balance on almost every 
organ of the body with differing yet, complimentary effects. 
The PNS is derived from the cranial nerves as well as in the spinal cord and is 
associated with the conservation of energy, allowing the body to "rest and digest" 
(Snitker, Macdonald, Ravussin, & Astrup, 2000). Activation of the PNS involves a 
reduction in heart rate, cardiac output, and blood pressure, facilitates digestion, and 
restores energy (Snitker et al., 2000). In the PNS, acetylcholine is the neurotransmitter 
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responsible for many of these effects on the body; especially slowing of the heart rate 
(Berntson et al., 1997). 
The SNS also derives from the spinal cord and prepares the body for the "fight or 
flight" response (Snitker et al., 2000). This involves vasoconstriction (reducing blood 
flow), increasing metabolic changes of fat and glucose, and higher blood pressure, 
cardiac output, and heart rate (Snitker et al., 2000). In the SNS, sympathetic 
neurotransmitters, such as the catecholamines epinephrine and norepinephrine, increase 
cardiovascular functioning when stimulated (i.e., heart rate; Berntson et al., 1997). The 
SNS affects adipose tissue, thermoregulation, and resting metabolic states (Tentolouris, et 
al., 2003). 
The ANS is the regulator of organ function throughout the body, including 
temperature, respiration, digestion, blood pressure, and heart rate (Berntson et al., 1997). 
The sinoatrial (SA) node, referred to as the heart's pacemaker, generates electrical signals 
throughout the heart allowing it to contract and pump blood (Spiers, Silke, McDermott, 
Shanks, & Harron, 1993). Specifically, the ANS controls the frequency at which the SA 
node triggers the initiation of each heart beat. Each time the SA node fires, a tall spike, 
called an R-wave, is detected by an electrocardiogram (ECG). An ECG is an electrical 
signal waveform used to discriminate and quantify normal and abnormal beat-to-beat 
changes in the heart between the two branches of the ANS (Berntson et al., 1997). The 
number of R-waves per minute provides the average heart rate for that minute (Berntson 
etal., 1997). 
There are five points (P, Q, R, S, and T) on the ECG waveform. These points 
follow a specific order and correspond to specific events occurring in the heart. The P-
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point represents the contraction of the heart's atria pumping the blood into the heart's 
ventricles. The time it takes for the heart's ventricles to fill up with blood is represented 
by the P-Q interval. Then, the electrical signal divides into the right and left branches on 
the heart's septum. This is depicted by the Q-point. The electrical signal leaves the right 
and left bundle branches via the Purkinje fibers and spreads rapidly across the ventricles 
causing them to contract. The left ventricle contracts an instant before the right ventricle 
and is represented by the R-wave. The S-point represents the contraction of the heart's 
right ventricle. Finally, the relaxation of the heart's ventricles is denoted by the T-point 
and then the cycle continues. 
Autonomic Dysfunction andHRV 
In healthy individuals, the beat-to-beat (R-R) intervals, (i.e., one R-wave to the 
next R-wave) are not evenly spaced (Berntson et al., 1997). These beat-to-beat 
fluctuations in heart rate are measured by heart rate variability (HRV). HRV is 
influenced by several factors, including age (Shannon, Carley, & Benson, 1987), gender, 
ethnicity (Sloan et al., 2008), circadian rhythms (Malpas & Purdie, 1990), exercise 
(Berntson et al., 1997), and postural changes (Pomeranz et al., 1985). HRV generally 
decreases between the ages of 5 and 10 years and continues to decrease with age (Finley, 
Nugent, & Hellenbrand, 1987). 
Because the cardiovascular system is modulated by the ANS, HRV is regarded as 
a useful, reliable, and noninvasive parameter to assess the sympathetic and 
parasympathetic functions of the ANS in newborns, children, adolescents, and adults 
(Task Force of the European Society of Cardiology the North American Society of 
Pacing Electrophysiology [TFESCNASPE], 1996). Fast-variations (high HRV) reflect 
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parasympathetic (vagal) modulation and slower variations (low HRV) reflect a 
sympathetic dominance over the parasympathetic tone (Berntson et al., 1997). The 
overall balance between the sympathetic tone and the parasympathetic tone of the 
autonomic state is referred to as sympathovagal balance and can also be assessed with 
HRV (Goldberger, 1999). 
Measuring HRV 
Currently there are several methods and techniques used to assess the ANS. The 
gold standard is selective pharmacological blockade of either the SNS or the PNS 
(Berntson et al., 1997). Typically, researchers use beta-blockers to block the SNS and 
atropine to block the PNS. For example, blocking the parasympathetic branch will alter 
the heart's response or functional state and thus, provide information on basal 
contribution of that branch to the autonomic control of the heart (Berntson et al., 1997). 
Similarly, pharmacological blockade can also provide an estimated index of the opposite 
branch's contribution (i.e., sympathetic activity) based on the remaining cardiac control 
after the blockade of the initial branch (i.e., parasympathetic activity; Berntson et al., 
1997). Although pharmacological blockades are expensive and have some limitations, 
such as incomplete blockades these direct measures, after cautious selection of drugs or 
dosages, provide valid and accurate assessments of cardiac autonomic function (Berntson 
et al., 1997). Based on this method, frequency components of HRV have been 
established (Akselrod, et al., 1985; Grossman & Kollai, 1993). 
Other accurate, yet more invasive techniques have been developed to assess ANS. 
During stressful states, the SNS is activated, and large quantities of epinephrine and 
norepinephrine are released into the body, causing an increase in blood pressure and 
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cardiovascular activity. Thus, based on plasma, turnover, and urinary excretion of 
catecholamine concentrations (Liatis, Tentolouris, & Katsilambros, 2004) as well as 
cardiac norepinephrine spillover, autonomic function can be assessed (Ewing, Martyn, 
Young, & Clarke, 1985). Microneurography is another approach which directly 
measures muscle sympathetic nerve activity (Eckberg & Sleight, 1992) and is associated 
with cardiac norepinephrine spillover (Wallin et al., 1992). 
Less invasive methods (e.g., orthostatic tests, Valsalva maneuver) also can be 
used to assess heart rate and blood pressure responses (Berntson et al., 1997). Although 
there are numerous specialized techniques, the two most commonly and widely used 
approaches to quantify HRV and autonomic function are time and frequency (power 
spectral) domain analyses (Berntson et al., 1997). Because accurate readings of the R-
waves are required for time and frequency domain analyses, continuous ECG recordings 
are used to calculate HRV (Berntson et al., 1997). 
Time Domain Analysis. HRV time domain methods are based on statistical 
calculations. There are two types of variables: indices derived from the direct 
measurement of R-R intervals and indices derived from the differences between 
successive R-R intervals (Spiers, et al., 1993). Time domain methods derived from direct 
measurement include the standard deviation of all the R-R intervals (SDNN), the 
standard deviation of the average R-R intervals for each 5 minute segment within a 
specified time period (SDANN), and the average standard deviation of all R-R intervals 
for each 5 minute segment within the ECG recording time (SDNNI; Kleiger, Stein, 
Bosner, & Rottman, 1992). 
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Time domain methods derived from the differences between R-R intervals include 
the percentage of differences between successive R-R intervals that are greater than 50 
milliseconds (ms) apart (pNN50) and the square root mean difference (in ms) of 
successive R-R intervals (rMSSD; Kleiger et al., 1992). Although all time domain 
indices provide information on the variability of the heart rate fluctuations, they are not 
identical; each index provides unique information. For example, the SDNN provides 
information on the total variance (power); and, the rMSSD and pNN50 reflect high 
frequency fluctuations (parasympathetic tone) and are inversely correlated with 
sympathovagal balance (Kleiger et al., 1992). 
Frequency Domain Analysis. Frequency domain analysis provides precise 
information on the number of heart rate fluctuations per second (Lahiri, Prince, 
Kannankeril, & Goldberger, 2008). The Fast Fourier Transform algorithm is used to 
calculate the maximum variability in the heart's rhythm based on a range of frequency-
specific oscillations of the R-R intervals (Lahiri et al., 2008; Spiers et al., 1993). These 
frequencies, when categorized into power bands, reflect different branches of the cardiac 
system. Total power (TP) covers all the frequencies and is used as an index of all of the 
variance over the recording period (Malliani, Pagani, & Lombardi, 1994). Very low 
frequency (VLF) ranges from 0.0033-0.04 Hz and has been reported to be influenced by 
thermoregulatory processes (Kitney, 1980). Low frequency (LF) ranges from 0.04-0.15 
Hz, and although many researchers have proposed that the LF reflects solely sympathetic 
activity, other studies indicate that LF reflects the aggregate influences of both 
sympathetic and parasympathetic branches of the ANS (Akselrod et al., 1981; Berntson et 
al., 1997). High frequency (HF) power ranges from 0.15-0.40 Hz and represents the 
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parasympathetic activity of the ANS affecting the SA node (Berntson et al., 1997; 
Pomeranz et al., 1985). 
Another frequency component is respiratory sinus arrhythmia (RSA), which 
ranges from 0.15-0.40 Hz (Berntson et al., 1997). Because the rate of breathing 
influences the frequency at which the SA node fires, and thus influences the heart rate, 
slow (e.g., exhalation) or fast (e.g., inspiration) breathing will produce differences in 
HRV (Berntson et al., 1997). For example, during inspiration heart rate increases, while 
during expiration, heart rate decreases (Berntson et al., 1997). RSA is mediated by 
several parasympathetic parameters, such as cardiac vagal tone (the differences in mean 
HRV between a resting baseline and a complete vagal blockade), baroflex activity, and 
respiratory function, and thus, is generally used as an indicator of the parasympathetic 
branch of the ANS (Berntson et al., 1997). 
Although HRV can be assessed by various techniques, time- and frequency-
domain analyses demonstrate significant associations between both types of analyses. 
Carrasco and colleagues (2001) found HF power was correlated with SDNN, pNN50, and 
rMSSD. LF power, reflecting both sympathetic and parasympathetic tone, correlated 
with SDNN, pNN50, and rMSSD. LF/HF ratio, indicative of sympathovagal balance, 
showed an inverse association with SDNN, pNN50, and rMSSD. Thus, either time or 
frequency HRV quantification methods can reliably assess autonomic influences on the 
cardiovascular system. 
Absolute and Normalized HRV Values. The LF and HF variables quantified by 
frequency domain analyses can be assessed in absolute values (milliseconds squared) or 
normalized units (fractional or percentage). Absolute values are the raw values generated 
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by the Fast Fourier Transform algorithm and reflect the modulation of either 
parasympathetic (HF) or both sympathetic and parasympathetic modulation (LF) of the 
ANS. However, because absolute values tend to show a long-tailed right skewed 
distribution and are more difficult to interpret, normalized values are preferred (Burr, 
2007). 
Normalized units are not direct calculations of raw data, but rather are secondary 
analyses computed only after LF and HF bands are statistically calculated (Burr, 2007). 
Normalized values, denoted with the suffix "«w" (e.g., LFnu and HFow), provide 
relatively easy interpretations of the proportion of each frequency bands, while 
controlling for total power within the power spectrum (Lahiri et al., 2008; Rabbia et al., 
2003). Thus, given the appeal and ease of normalized values, many researchers report 
HRV measures in normalized units. Normalized units do not provide unique information 
about the modulation of either sympathetic or parasympathetic tones, but instead provide 
information on the overall modulation of both branches of the ANS (Burr, 2007). 
Consequently, problems in data interpretation have been noted (Busek et al., 2005; 
Robert et al., 2006; Sforza et al., 2007). Thus, it is highly recommended that researchers 
report both absolute and normalized values of the frequency power bands in order to 
describe completely the distribution of power in spectral components (TFESCNASPE, 
1996). 
Cardiovascular Autonomic Dysfunction and HRV 
When assessing the cardiovascular system, an equal balance between the 
sympathetic and parasympathetic branches of the ANS represents a healthy autonomic 
function in the heart. However, when there is a dysregulation between the two branches 
21 
of the ANS, cardiovascular autonomic dysfunction develops (Messerli, Nunez, Ventura, 
& Snyder, 1987). Cardiovascular autonomic dysfunction, a marker of negative 
cardiovascular risk (e.g., stroke, coronary heart disease, myocardial infarction, angina, 
etc.), is characterized by a substantial decrease in HRV, denoted by reduced 
parasympathetic input (indicative of an inactive or damaged PNS) and an elevated 
sympathetic tone (Berntson et al., 1997). 
The decreased vagal tone and increased sympathetic tone confer risk for 
ventricular fibrillation, a medical condition which causes disruptions in the contractions 
of the ventricles of the heart, preventing blood circulation and even causing death 
(Billman & Hoskins, 1988; Hull et al., 1990; Molgaard, Sorensen, & Bjerregaard, 1991). 
Conversely, an increased vagal tone is considered a protective factor because as it 
increases, the electrical signal that stimulates coordinated contractions in the ventricles of 
the heart allows blood to pump into the body (Berntson et al , 1997; Stein & Kleiger, 
1999). 
Autonomic dysfunction among adult patients is associated with chronic renal 
failure (Agarwal, Anand, Sakhuja, & Chugh, 1991), essential hypertension (Radaelli et 
al., 1994), diabetes (Stein & Kleiger, 1999), coronary artery disease (Dekker et al., 2000), 
left ventricular dysfunction (Nolan et al., 1992) congestive heart failure (Casolo, et al., 
1989; Mortara et al., 1994), and obesity (Aronne, Mackintosh, Rosenbaum, Leibel, & 
Hirsch, 1997). Decreased parasympathetic tone is a significant risk factor for sudden 
cardiac death in post myocardial infarction patients (Hartikainen, Fyhrquist, 
Tahvanainen, Lansimies, & Pyorala, 1995), and increased sympathetic activity has been 
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linked to a five-fold increased likelihood of mortality in post-myocardial infraction 
patients up to 272 years later (Bigger et al., 1992; Wolf, et al., 1978). 
Even among healthy adult populations, prospective studies show that dampened 
HRV is a significant predictor of the development of hypertension (Liao et al, 1996), 
new cardiac events, as well as morbidity, and mortality, even after controlling for other 
clinical co-morbidities (Dekker et al., 1997; Tsuji et al., 1996). In youth, autonomic 
dysfunction is associated with diabetes (Akinci, Celiker, Baykal, & Tezic, 1993), atrial 
septal defect (Finley, Nugent, Hellenbrand, Craig, & Gillis, 1989), and obesity (cf. 
Kaufam et al., 2007; Rabbia et al., 2003). Interestingly, autonomic dysfunction is also 
linked with sleep disorders in adults and in children, including chronic fatigue syndrome 
(Stewart, Weldon, Arlievsky, Li, & Munoz, 1998), sleep-disordered breathing (O'Brien 
& Gozal, 2005), obstructive sleep apnea, and insomnia (Bonnf & Arand, 1998). 
Indeed, based on this relation, recent data suggests that sleep loss (i.e., reduced 
sleep duration), through the dysregulation of ANS, may be a risk factor involved in the 
development of eventual health problems (Meerlo, Sgoifo, & Suchecki, 2008). Given 
that sleep is considered a time for the heart to rest and reduce its workload, sleep loss can 
actually increase the heart's workload, especially during specific sleep stages when the 
vagal tone relaxes the heart and cardiac output (Wolk, Garni, Garcia-Touchard, & 
Somers, 2005). In fact, sleep loss is associated with several adverse health conditions, 
including psychiatric disorders (Chang, Ford, Mead, Cooper-Patrick, & Klag, 1997), 
heart disease (Ayas et al., 2003), and obesity (Patel, Malhotra, White, Gottlieb, & Hu, 
2006). Thus, it is postulated that autonomic dysfunction is one pathogenic mechanism 
underlying the relation between sleep and obesity. 
23 
Sleep 
One-third of human life is spent sleeping; and therefore, it is no surprise that sleep 
has a profound impact on fundamental homeostatic mechanisms in the body (Thompson, 
Ackermann, & Horner, 2001). Sleep is an intricately organized process regulated by the 
two-process model which involves the interaction between homeostatic and circadian 
processes (Achermann & Borbely, 2003; Daan, Beersman, & Borbely, 1984). The 
homeostatic process attempts to keep the amount of prior wakefulness and sleep 
balanced, so that during wakefulness sleep propensity (sleepiness) increases and will 
compensates for sleep loss (Achermann & Borbely, 2003). 
The other component of sleep involves the circadian timing system, which 
regulates behavioural and physiological processes (Rosenwasser & Turek, 2005). It is 
regulated by the suprachiasmatic nucleus (Weaver, 1998) and follows a rhythmic pattern 
over 24 hours (Laposky et al., 2008). Circadian markers (e.g., melatonin and core body 
temperature; Cajochen & Dijk, 2003) and clock genes have been associated with "early 
birds" (morning preference) or "night owls" (evening preference; Archer et al., 2003; 
Duffy, Dijk, Hall, & Czeisler, 1999). Circadian rhythms affect the timing and structure 
of sleep (Dijk & Czeisler, 1995). 
Sleep Structure 
Sleep is composed of two major states: rapid eye movement (REM) and non-rapid 
eye movement (NREM). REM is further divided into tonic and phasic states. Tonic 
sleep occurs throughout REM sleep and includes muscle atonia and increased brain 
activity (Goldsmith, Casola, & Varenbut, 2006). Conversely, phasic states appear 
intermittently during REM sleep and are characterized by bursts of rapid eye movements, 
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muscle twitches, and vasoconstriction (Goldsmith et al., 2006). REM is characterized by 
the greatest frequency and intensity of dreaming and is associated with the consolidation 
of memory and learning (Maquet, 2001). Generally, during REM sleep there is an 
increase in heart rate, blood pressure, and respiration compared to NREM sleep 
(Goldsmith et al , 2006; van Eekelen, Varkevisser, & Kerkhof, 2003). 
NREM sleep is subdivided into four stages: 1, 2, 3 and 4. Stage 1 reflects the 
transition from wake state to sleep. Stages 1 and 2 are referred to as light NREM sleep 
because the arousal threshold is lower. Conversely, stages 3 and 4 are referred to as deep 
or slow-wave-sleep (SWS), as these stages are characterized by an increase in slow wave 
activity or delta waves and the arousal threshold is higher (Gais, Plihal, Wagner, & Born, 
2000). In particular, SWS is recognized as providing the most quality and restorative 
sleep and is involved in memory transfer and consolidation from daytime activity (Gais et 
al., 2000; Stickgold, 2005; Stickgold, Hobson, Fosse, & Fosse, 2001). During NREM 
sleep, brain activity, heart rate, cardiac output, breathing, and blood pressure decrease 
and are stable compared to wakefulness and REM sleep (Goldsmith et al., 2006; van 
Eekelen et al., 2003). 
Throughout the night, sleep is divided into a 90-110 minute cycle of REM and 
NREM sleep that is repeated 4-6 times during the night. During the earlier portion of 
sleep, NREM sleep is predominant compared to REM sleep, with approximately 2-5% in 
Stage 1, 45-50% in Stage 2 (characterized by sleep spindles and K complexes), 5-8 % in 
Stages 3 and, 10-15% in Stage 4 (Rechtschaffen & Kales, 1968). As the night 
progresses, REM sleep becomes gradually longer and is predominant compared to 
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NREM sleep, occupying 20-25% of sleep (Rechtschaffen & Kales, 1968; Thompson et 
al., 2001). 
Measuring Sleep 
There are several ways to assess sleep duration and sleep quality. Most are 
subjective methods with questions asking participants to estimate their bed- and wake-
times, the number of hours of sleep they obtain each night, and to rate their sleep quality 
on a Likert scale. Validated questionnaires are also used to determine sleep problems 
related to falling asleep, snoring, night terrors, parasomnias, and daytime sleepiness. 
Other methods include sleep diaries, which ask the participant to record the activities they 
are doing throughout the entire day, including what time they started and ended the 
activity (e.g., sleeping, etc.). Sleep diaries are usually filled out for 4-7 days to determine 
typical sleep/wake patterns in participants. Sleep diaries are a reliable method for 
estimating the amount of time spent on an activity and have been cross-validated with 
objective measures of sleep duration (Gaina, Sekine, Chen, Hamanishi, & Kagamimori, 
2004; Robinson, 1985). 
Wrist actigraph is an objectively measured method based on a non-invasive small 
device worn like a watch on the non-dominant arm for 5-7 days (Lockley, Skene, & 
Arendt, 1999). It monitors and calculates the participant's overall motor activity during 
the day and night, and calculates "resting" and active periods. Sleep duration and sleep 
quality based on disturbed or active movements during the night can be assessed and are 
considered reliable measures of sleep (Lockley et al., 1999). 
Because there are distinct physiologic processes that occur during sleep, it is 
deemed most accurate to capture and categorize distinct sleep stages with 
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polysomnograph (PSG), the gold standard of measuring sleep. PSG continuously records 
physiological parameters, including brain wave activity and eye activity, that define 
wakefulness and sleep and is used for diagnosing a wide range of sleep disorders (e.g., 
obstructive sleep apnea), measuring sleep duration, sleep efficiency, and sleep latency 
(e.g., sleepiness), as well as quantifying sleep architecture (i.e., percent of time spent in 
each sleep stage) in adults and children (Acebo et al., 1996). 
PSG is usually conducted during a single night in a laboratory or hospital setting 
by a trained technician to ensure the quality of the study. The minimal requirements for a 
sleep study typically include at least one channel for electroencephalogram (EEG) to 
detect cortical brain activity, two electroculograms (EOG) to detect right and left eye 
movements, and one electromyogram (EMG) to detect submental muscle and postural 
movements (Rechtschaffen & Kales, 1968). In addition, other measures can be used 
including a nasal cannula to measure airflow, pulse oximeter to measure blood oxygen 
levels, and an ECG monitor to measure heart rate. Trained sleep technicians manually 
review the raw data on consecutive epochs lasting 30 seconds and score sleep stages 
based on the standard rules of Rechtschaffen and Kales (1968). PSG is also used to 
measure daytime sleepiness, referred to as a state with an increased risk of falling asleep 
(Fallone, Owens, & Deane, 2002). Sleep latency is the time (in min) it takes to fall 
asleep; the shorter the latency, the greater sleepiness (Carskadon et al., 1986). 
Although PSG in the laboratory is the gold standard of measuring sleep, it is 
expensive, invasive, and may affect the quality of sleep because it is conducted in an 
unfamiliar setting. Recently due to technological advancements in developing 
ambulatory equipment, there has been an increase in the use of unattended home PSG 
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recordings; that is, no certified technician attaching the electrodes, but simply teaching 
the participants how to attach the electrodes. Evidence suggests that home PSG sleep 
studies, with proper signal detection and low impedance, can be used to obtain accurate 
physiological data, in spite of age, sex, and BMI of participants (Iber et al., 2004; Kapur 
et al., 2000). 
Sleep and its Correlates 
Quality uninterrupted sleep is associated with physical growth and health, disease 
resistance, injury prevention, and emotional stability (Carskadon, 1999; Kelman, 1999). 
Conversely, lack of quality sleep adversely impacts daily living, reduces quality of life, 
and is associated with poor health status (Leger, Scheuermaier, Philip, Paillard, & 
Guilleminault, 2001). Disturbed sleep and longer sleep latency predict an increased all-
cause mortality, even after adjusting for age, gender, medical comorbidities, and 
psychological disorders (Dew et al., 2003). 
Unfortunately, due to the changes of modern day life, the importance of sleep has 
been less emphasized. Over the past 40 years sleep duration has decreased by 1-2 hours 
(Kripke, Simons, Garfinkel, & Hammond, 1979; National Sleep Foundation [NSF] 
Survey, 2000; 2001). The number of young adults sleeping less than 7 hours has 
increased more than two-fold from 15.6% in 1960 to 37.1% in 2001 (Kripke et al., 1979; 
NSF Survey, 2000; 2001). Currently, based on recommended sleep duration for youth 
(NSF, 2006), 15 million youth do not obtain the necessary amount of sleep (Smaldone, 
Honig, & Byrne, 2007). 
Adequate sleep requirements are age-dependent, with younger children needing 
more sleep and older youth needing less sleep (Heussler, 2005). According to the 
28 
National Sleep Foundation (NSF, 2006) children aged 5-12 years should be getting 9-11 
hours each night and adolescents should be getting approximately 8.5-9.5 hours each 
night (Carskadon, 1999). Given that sleep is a critical time in which important 
physiological processes occur, it is no surprise that sleep problems contribute a large 
portion to the economic burden of direct (e.g., managing sleep disorders), indirect (e.g., 
work-related injuries, production loss), and non-financial health costs (e.g., premature 
death, diminished quality of life); and thus, sleep is especially critical for the healthy 
development of children (Hillman, Murphy, Antic, & Pezzullo, 2006). 
Sleep in Youth 
Processes related to maturation and environment influence and change sleep 
structure and sleep duration from childhood to adolescence. In general, total sleep 
duration decreases from ~15 hours at 6 months to 8 hours at 16 years (Iglowstein et al., 
2003). During the first year, daytime sleeping gradually decreases and night time 
sleeping gradually increases, incorporating 84% of total sleep duration; thereafter a 
pronounced reduction in night time sleep is observed (Iglowstein et al., 2003). Five to 6 
year-olds sleep -11 hours (Iglowstein et al., 2003; Wolfson, 1996), 7-9 year-olds sleep 
-10.5 hours, and 10-12 year-olds sleep 9.3 hours each night (Howard & Wong, 2001; 
Iglowstein et al., 2003; Stein et al., 2001). Additionally, across development, children 
show decreased REM sleep and increased SWS (Carskadon & Dement, 1987; Heussler, 
2005). 
During adolescence, hormonal, developmental, and social changes accompany 
marked changes in sleep patterns (Anders, Carskadon, Dement, 1980). Adolescents' 
have later bed times (11 p.m. or later) but unchanged wake times, have longer sleep 
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latencies, and experience more awakenings and fragmented sleep compared to children 
(Carskadon, Wolfson, Acebo, Tzischinsky, & Seifer, 1998; Gau & Soong, 2003; 
Iglowstein et al., 2003). In addition, sleep duration reduces from 9 to 8.1 hours each 
night, although their sleep need does not decrease (Carskadon, 1999). 
Sleep Problems in Youth 
Recent studies have found that almost 50% of adolescents report sleeping 1-2 
hours less per night than the recommended 9 hours per night and -60% report feeling too 
tired or sleepy during the day (NSF Survey, 2006). Daytime sleepiness is associated with 
adversely impacting youth's daily activities, mood, driving, and academic performance 
(Fallone et al., 2002). About 20% of students report falling asleep while doing their 
homework, 25% fall asleep during school, and 14% are late or miss school at least once a 
week due to oversleeping (NSF Survey, 2006). 
Furthermore, worldwide studies have estimated that between 20-41% of children 
(Archbold, Pituch, Panjabi, & Chervin, 2002; Sadeh et al., 2000) and 6-37% of 
adolescents (Liu, Uchiyama, Okawa, & Kurita, 2000) report sleep problems related to 
initiating and maintaining sleep, daytime sleepiness, and poor sleep quality. 
Additionally, poor sleep quality is associated with disturbances in behaviour and mood in 
children (Lavignen et al., 1992; Sadeh, Gruber, & Raviv, 2003). Other problems include 
parasomnias (e.g., nightmares, night terrors, sleep walking) and bedtime resistance (e.g., 
stalling to go to bed or frequent times getting out of bed before sleeping) (Owens, Spirito, 
& McGuinn, 2000; Sadeh et al., 2000; Stein et al., 2001). 
These sleep problems may confer risk for sleep debt/deprivation, daytime 
sleepiness, prolonged sleep delay onset, and insomnia in both children and adolescents 
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(Hoban & Chervin, 2001), all which have been linked to emotional and behavioural 
problems as well as biological and physiological processes. 
Sleep Loss and Sleep Structure 
Following sleep loss, only up to 85% of sleep can be recovered, suggesting that 
short sleepers may carry a sleep debt (Klerman & Dijk, 2005). In a clinical study, 
healthy adults whose sleep was restricted to 4, 6, or 8 hours over 2 weeks showed no 
signs of compensation in either sleep duration or time spent in SWS during sleep 
opportunities (Van Dongen, Maislin, Mullington, & Dinges, 2003). During sleep debt 
conditions, a significant decrease in the time spent in light NREM (Stages 1 and 2) and 
REM sleep occurs and this is compensated for with an increase time spent in SWS 
(Stages 3 and 4). Conversely, during sleep recovery, an increase time spent in light 
NREM and REM sleep occurs (Spiegel et al., 1999; 2004). These changes reflect 
alterations in sleep structure, with the suppression of REM sleep and preservation of 
SWS during sleep restriction, and an increase rebound of REM sleep during sleep 
recovery. 
Adequate "Normal" Sleep and Autonomic Dysfunction 
The ANS regulating cardiovascular function demonstrates distinct changes as a 
result of sympathetic and parasympathetic influences throughout the sleep cycle. PSG 
and ECG monitoring are used to identify rapid fluctuations of cardiac activity during 
sleep stages. During NREM sleep, the parasympathetic system exerts its greatest 
influence on the cardiac system with higher HF and lower LF components compared to 
REM (Ako et al., 2003; Bonnet & Arand, 1997; Burgess, Trinder, & Kim, 1996; 
Elsenbruch et al., 1999; Trinder et al., 2001). From Stages 1-4 there is a linear increase 
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in parasympathetic activity (van Eekelen et al., 2003) and a progressive and significant 
reduction in LF/HF ratio (Toscani et al., 1996). In particular, during Stage 2 there is a 
significant increase in sympathovagal balance (e.g., greater sympathetic activity and 
reduced parasympathetic activity) compared to SWS (Toscani et al., 1996). 
Conversely, during the transition to REM sleep, a decrease in parasympathetic 
contribution and an increase in sympathetic dominance on the cardiac autonomic balance 
is observed (Berlad, Shlitner, Ben-Haim, & Lavie, 1993; Bonnet & Arand, 1997; Trinder 
et al., 2001; van Eekelen et al., 2003; Vanoli et al, 1995). Compared to SWS, REM is 
characterized by high HRV (Morgan et al., 1996), high LFnu and LF/HF ratio (Ako et al., 
2003), as well as high SDNN values (Brandenberger, Buchheit, Ehrhart, Simon, & 
Piquard, 2005). 
In general, both parasympathetic and sympathetic activity contribute to cardiac 
modulation during normal sleep. However, there is sleep-stage dependence; vagal tone 
increases during NREM sleep, especially during SWS, and sympathovagal balance, that 
is sympathetic activation, increases during REM sleep. 
Inadequate Sleep and Autonomic Dysfunction 
Evidence in animals and humans has demonstrated a profound relation between 
sleep loss and autonomic dysfunction. Recently, Sgoifo and colleagues (2006) deprived 
rats of sleep for 48 hours by placing them on a slowly rotating wheel. Compared to 
controls, sleep deprived rats showed significantly reduced HRV, SDNN, and rMSSD 
values, reflective of parasympathetic withdrawal, during dark phases and especially 
during light phases. In addition, sleep deprived rats showed elevated heart rate for the 
following two days during sleep recovery. This experimental data demonstrates that 
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sleep loss alters cardiac autonomic function, inducing vagal withdrawal and sympathetic 
activation, and has lasting effects, particularly during resting conditions. 
Similar results have been found in humans, with sleep loss leading to autonomic 
dysfunction. Numerous studies have demonstrated that total and partial sleep deprivation 
leads to significant increases in heart rate, blood pressure (Lusardi et al., 1996; Ogawa et 
al., 2003; Tochikubo et al., 1996), sympathovagal balance (Tochikubo et al., 1996), 
norepinephrine and epinephrine levels (Irwin et al., 1999; Tochikubo et al., 1996), and a 
significant decrease in HRV upon awakening compared to baseline (Ewing, Neilson, 
Shapiro, Stewart, & Reid, 1991). 
In another experimental study, (Spiegel et al., 2004) 11 healthy men underwent 6 
nights of 4 hours of sleep (sleep debt) and 6 nights of 12 hours of sleep (sleep recovery). 
Dampened 24-hour HRV was observed during sleep debt and sympathovagal balance 
significantly increased during sleep recovery. This sympathetic activation was especially 
seen in the morning (9 a.m.-l p.m.) and afternoon (1-5 p.m.), suggesting that reduced 
sleep negatively influences cardiac autonomic function, especially in the early part of the 
day following sleep loss. Similar results were seen among healthy men who slept 4 hours 
for 5 consecutive nights (American Academy of Sleep Medicine, 2007). 
Franco and colleagues (2003) compared HRV measures in 12 infants in either a 
sleep deprived (for 2 hours before napping) or control condition. Sleep deprived infants 
had significantly reduced HRV during REM sleep and significantly elevated LF power 
and LF/HF ratio during NREM sleep compared to the control condition (p<.0\). 
Evidence suggests that even losing 2 hours of sleep has the potential to change cardiac 
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autonomic function. However, due to the limited sample size (low power), no statistical 
differences in the HF power were observed. 
Brief arousals during sleep are also associated with an increase in heart rate and 
blood pressure (Ekstedt et al., 2004; Sforza et al., 2004) and both heart rate and blood 
pressure can remain elevated for up to 40 sec after the arousal (Blasi et al., 2003; Sforza 
et al., 2006). Compared to normal sleepers, individuals with sleep apnea or insomnia 
have an elevated heart rate and a progressive increase in sympathetic activity during sleep 
and wakefulness, (Narkiewicz & Somers, 2003) as well as a decrease in parasympathetic 
tone (Bonnet & Arand, 1997). Tasali and colleagues (2008) examined HRV in 9 healthy 
adults after three consecutive nights of SWS suppression, where acoustic stimuli of 
different frequencies and intensities were administered during SWS. LFnu and LF/HF 
ratio were significantly elevated and HFnu was significantly reduced after SWS 
suppression compared to baseline, even after controlling for breathing frequency and total 
sleep and wake time. 
Indeed, data demonstrates that reduced, disturbed, and fragmented sleep are 
associated with autonomic dysfunction. In fact, being in a state of sleep debt alters the 
normal modulations of the ANS, and even losing 2 hours of sleep requires greater 
sympathetic activation to awaken and maintain wakefulness for the rest of the day. 
Autonomic Dysfunction and Obesity 
The imbalance between the parasympathetic and sympathetic systems of the ANS 
has been proposed to play a role in the onset of obesity in animal models and in humans. 
However, there are inconsistent findings in terms of where (i.e., PNS/SNS) the changes 
on the ANS occur and how they contribute to the etiology of obesity. Some studies 
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report changes in both PNS and SNS (Aronne et al., 1997; Emdin al., 2000; Karason, 
Molgaard, Wikstrand, & Sjostrom, 1999); others report changes only in the PNS or only 
in the SNS (Richter, Geiss, Aleksic, & Schwandt, 1996; Rossi et al., 1989; Valensi et al., 
1998); while others report no changes in either branch (Petretta et al., 1995; Piccirillo et 
al , 1996; Piha, Ronnemaa, & Koskenvuo, 1994). 
Parasympathetic and Sympathetic Activity and Obesity. Regardless of 
methodology or sample size, reduced parasympathetic activity has been consistently 
found to be associated with obesity (Laederach-Hofman, Mussgay, & Ruddel, 2000; 
Richter et al., 1996; Rossi et al., 1989; Valensi et al., 1998). Parasympathetic under-
activity has been found to be inversely associated with an increased percent body fat 
(Peterson, Rothschild, Weinberg, Fell, McLeish, & Pfeifer, 1988), BMI (Freeman, Weiss, 
Roberts, Zbikowski, & Sparrow, 1995), triglyceride concentrations (Sajadieh, Nielson, 
Rasmussen, Hein, & Hansen, 2005), and body weight (Hirsch, Leibel, Mackintosh, & 
Aguirre, 1991). In fact, a decline in HF power is associated with a 10% increase in body 
weight (Hirsch et al., 1991). 
There is evidence suggesting an association between sympathetic activity and 
obesity, however, the mechanism by which sympathetic activation promotes obesity is 
unclear. However, because SNS influences the body through direct (e.g., P-receptors) 
and indirect effects (e.g., cardiovascular system), data suggests that sympathetic 
activation may contribute to the development of obesity. Findings are inconsistent as 
some research suggests low sympathetic activation leads to obesity and other research 
suggests that high sympathetic activation leads to obesity (Ravussin & Tataranni, 1996). 
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Animal Models. Numerous studies have investigated the link between autonomic 
dysfunction and obesity in animal models. One hypothesis is the MONA LISA 
Hypothesis, an acronym for "Most Obesities kNown Are Low In Sympathetic Activity" 
(Bray, 1991). The MONA LISA Hypothesis is based on animal studies which indicate 
that reduced SNS activity is associated with and is a causal risk factor for obesity (Bray, 
1991; Bray, York, & Fisler, 1989). In genetically obese (e.g., ob/ob mouse and the fa/fa 
rat) and ventromedial hypothalamus-lesioned rodents (i.e., hypothalamic obesity) brown 
adipose tissue showed significantly deceased sympathetic and increased parasympathetic 
activity. Rodents also exhibited decreased energy expenditure and increased food intake 
and weight gain (Knehans & Romsos, 1983; Levin et al., 1983; Niijima et al., 1984). 
Lesions to the lateral hypothalamus showed elevated sympathetic activity and reduced 
food intake and body weight (Bray, 1991). While, lesions to fas paraventricular nucleus 
showed no significant changes in either autonomic function or food intake (Fukushima, 
Tokunaga, Lupien, Kemnitz, & Bray, 1987). These findings suggest that functions of the 
ANS are uniquely altered in both genetic and hypothalamic forms of obesity in rodents, 
yet depend on the location where damage to the hypothalamus is found. 
In contrast, Landsberg (1986) suggests that sympathetic activation may contribute 
to the development of obesity. Experimental animal studies demonstrate that fasting 
suppresses sympathetic activity (Young & Landsberg, 1977), while increased food intake 
stimulates sympathetic activity (Young, Saville, Rothwell, Stock, & Landsberg, 1982). 
Recently, the sympathetic neural transmitter neuropeptide Y, an important orexigenic 
peptide involved in the production of white adipose tissue (Kalra & Kalra, 2004), has 
provided new evidence in elucidating the role of autonomic dysfunction in the 
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development of obesity. Neuropeptide Y is associated with increased food intake, 
especially of carbohydrate-rich foods, and has been found in the brain in many forms of 
experimental obesity (Kalra & Kalra, 2004). Kuo and colleagues (2007) demonstrated 
that in mice, under conditions of stress (i.e., cold and/or aggression) and a high-fat diet, 
the release of neuropeptide Y lead to the development of abdominal obesity within two 
weeks compared to controls. These findings support the notion that SNS plays an 
important role in the development of obesity and suggest that stress, (and hence 
activation of the SNS and withdrawal of the parasympathetic activity) may be a potential 
catalyst. 
Human Studies. Several studies suggest that autonomic dysfunction is related to 
obesity in humans. Similar to most animal models, some research suggests that reduced 
sympathetic activity precedes obesity. In a prospective study of Pima Indians, decreased 
baseline measures of SNS activity (i.e., low urine epinephrine and norepinephrine 
concentrations) were associated with weight gain and the development of central obesity 
3 years later (Spraul et al., 1993; Tataranni, Young, Bogardus, & Ravussin, 1997). Given 
that Pima Indians are genetically susceptible to obesity and diabetes and have low rates of 
hypertension, these results cannot be generalized to other populations (Tataranni et al., 
1997). Recently, Flaa and colleagues (2008) found reduced concentrations of 
epinephrine to stress tasks at baseline predicted increased changes in BMI and waist 
circumference 18 years later in Caucasians. This may suggest that low SNS activity is 
involved in the etiology of obesity in animal models and in humans. 
Conversely, other research suggests that sympathetic activation leads to obesity 
since sympathetic activation is associated with increasing body weight (Masuo, Mikami, 
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Ogihara, & Tuck, 2001; Vaz, Jennings, Turner, Cox, Lambert, & Esler, 1997), blood 
pressure, heart rate, and cardiac output (Reaven, Lithell, & Landsberg, 1996). Masuo and 
colleagues (2003) demonstrated that increased blood pressure and resting plasma 
norepinephrine at baseline predicted more than a 10% increase in BMI and subsequent 
weight gain over a 5-year period. In fact, greater baseline norepinephrine concentrations 
predicted individuals who were resistant to losing weight and predicted individuals who 
experienced rebound weight gain, even after successfully losing body weight over 24 
months (Masuo et al., 2005). Branth and colleagues (2007) also demonstrated that 
sympathetic activation, triggered by stress, predicted the development of abdominal 
obesity, increased body fat and blood pressure in sailors 5 months later, despite regular 
exercise and a controlled diet. 
These conflicting results may be attributable to methodology. The studies used 
different indices of sympathetic activation (i.e., norepinephrine concentrations, blood 
pressure, heart rate, etc.) and although all reflect sympathetic activation, differences were 
observed depending on the physiological outcome variable of interest (i.e., cardiac 
system, renal system, and adipose tissue; Davy & Orr, 2008). 
Autonomic Dysfunction and Childhood Obesity 
Nagai and colleagues (2003; 2004) had 42 obese and healthy youth wear an ECG 
monitor for 4.5-5 minutes. Based on absolute HRV values, heavier children showed 
reduced TP, LF (p<0.05), and HF (p<0.0\) compared to controls. Consistent with the 
adult literature, obese children showed reduced parasympathetic activity. The authors 
claimed that based on the LF band, only sympathetic activity was significantly reduced 
among obese children. However, because the LF encompasses both sympathetic and 
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parasympathetic activity, these conclusions should be interpreted with caution. 
Unfortunately, neither time-domain analyses nor the LF/HF ratio were included in these 
studies, which could have provided additional information on the modulation and 
sympathovagal balance of the ANS in children. 
Recently, Kaufman and colleagues (2007) investigated cardiac functioning of 
overweight/obese and healthy youth aged 10-13 years old. Based on 15 minutes of HRV 
data, overweight/obese youth showed signs of autonomic dysfunction with a 
sympathetically driven cardiac system (LF/HF ratio and LFnu) and a hypoactive 
parasympathetic tone (HFnu, SDNN, and rMSSD values) compared to healthy controls. 
Similar findings were found by Riva, et al (2001) when HRV was analyzed for 24 hours 
in non-diabetic obese («=23) and in healthy adolescents («=14). Overall, obese youth 
had lower SDNN, pNN50, and rMSSD values, reflective of reduced parasympathetic 
activity, compared to lean controls. Sympathetic activity showed an inverse pattern, with 
obese youth showing greater LFnu and LF/HF ratio values, especially during the night 
compared to healthy youth. 
Martini and colleagues (2001) had 32 non-diabetic obese youth and 13 healthy 
sex-matched controls wear an ECG Holter monitor for 24 hours. Obese youth had 
significantly lower pNN50, rMSSD values, and HFnu values, and greater sympathovagal 
balance (LF/HF ratio) during the night compared to healthy controls. Also, BMI was 
inversely correlated with night time HFnu values. Thus, obese youth showed significant 
parasympathetic under-activity and sympathetic over-activity, especially during nocturnal 
hours compared to their lean counterparts. 
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Rabbia and colleagues (2003) compared cardiac autonomic function in 50 non-
diabetic obese youth and 12 healthy controls. Unlike previous studies, youth were 
categorized into recently, intermediate, and long-term obese groups; youth who snored or 
had sleep apnea were excluded from the study. Based on 24 hour HRV recording, obese 
youth from all duration categories had lower SDNN, pNN50, rMSSD, and TP values 
compared to healthy controls. Particularly, during the night period, rMSSD and UVnu 
values were significantly lower as well, LFnu and LF/HF ratio values were significantly 
elevated among obese youth compared to healthy controls. Consistent with previous 
findings, Rabbia and colleagues (2003) found obese youth show autonomic dysfunction. 
Interestingly, even after excluding youth with snoring and sleep apnea, this aberrant 
pattern was seen especially during nocturnal hours. 
These cross-sectional studies provide support for the association between reduced 
HRV, characterized by diminished parasympathetic function, and a predominance of 
sympathetic function particularly during "sleep" periods in youths with excess adipose 
tissue. Increased adiposity may prevent the heart's ability to rest and reduce its workload 
during sleep, thus, predisposing obese youth to cardiovascular risk. 
Clearly, there is strong evidence supporting a link between autonomic dysfunction 
and obesity in adults and children. Some studies suggest that low sympathetic activation 
is a risk factor for future weight gain and others suggest that the increase in SNS activity 
may contribute to obesity. These inconsistent findings may be attributed to differences in 
methodology. However, since findings consistently suggest that parasympathetic activity 
is reduced and because autonomic function reflects the constant balance between both 
parasympathetic and sympathetic activity, it is difficult to assume that both branches are 
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inactive. Rather, it makes logical sense to have one branch under-active 
(parasympathetic) and the other over-active (sympathetic). The proposed mechanism 
underlying autonomic dysfunction (reduced parasympathetic activity and elevated 
sympathetic activity) is likely the increased secretion of catecholamines, which in turn 
increases food intake, weight gain, and a reduction in energy expenditure. Collectively, 
these studies have provided evidence suggesting a potential pathway, whereby autonomic 
dysfunction contributes to the pathogenesis of obesity. 
Rationale for Present Study 
Based on the studies presented, the potential pathogenic mechanism underlying 
the association between and obesity is autonomic dysfunction. First, there is strong 
evidence linking short sleep duration and obesity. Research findings have demonstrated 
that reduced sleep duration predicts future weight gain and obesity in youth. Second, 
based on experimental studies, sleep loss has been proposed as a causal risk factor in the 
development of autonomic dysfunction, such that reduced sleep alters autonomic 
functioning for up to 2 days after sleep debt. Third, because autonomic dysfunction is 
associated with obesity; increased sympathetic activation and its correlates have been 
implicated as the underlying link between sleep and obesity. By combining experimental 
and epidemiological data, it seems conceivable that autonomic dysfunction may promote 
increased food intake by stimulating the SNS, which in turn leads to increased fat 
deposition and the onset and maintenance of obesity. Considering that reduced sleep is a 
hallmark of modern society, it is no surprise that obesity prevalence rates have increased 
so dramatically. 
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Although researchers have begun to explore this adverse trajectory of losing 
sleep, exhibiting a decrease in HRV, eating, and gaining weight in adults, the association 
between these factors remains to be examined in children and adolescents. To date, there 
are no studies which have measured cardiac functioning while experimentally 
manipulating youth's sleep duration (e.g., depriving and extending sleep). The majority 
of studies in youth have been cross-sectional and prospective, and while these studies 
have provided convincing findings on the link between short sleep duration and weight 
gain, many were not purposely designed to evaluate sleep (i.e., sleep was not the primary 
variable of interest). Furthermore, most of these studies obtained sleep information about 
duration and quality via questionnaires, or sleep diaries from child- and parent-reports 
instead of using objective measures (e.g., wrist actigraph, PSG). 
Interestingly, while researchers have started to explore individual factors such as 
sleep-related behaviours and beliefs and knowledge about sleep hygiene, all which may 
play important roles in linking sleep with the likelihood of becoming obese, there is still a 
paucity of research aimed at elucidating the pathophysiological mechanisms underlying 
the link between sleep and obesity. 
The Present Study 
The present study is designed to extend the understanding of the underlying 
mechanisms of autonomic function during different sleep stages in children and 
adolescents of varying weight status. Specifically, the goal of the study is to evaluate 
whether autonomic dysfunction is one of the pathophysiological mechanisms underlying 
the association between sleep and obesity in children and adolescents. The results of this 
study will provide new knowledge about how autonomic dysfunction may mediate the 
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association between short sleep duration and obesity in boys and girls. There are primary 
and secondary hypotheses associated with the objective of the present study. 
Primary Hypotheses 
First, it is hypothesized that there will be a negative linear relation between sleep 
duration and obesity indices, such that youth with shorter sleep duration will have greater 
obesity values, measured by anthropometric measures (e.g., BMI, BMI percentile, waist 
circumference, percent body fat). 
Second, it is hypothesized that short sleep duration will predict autonomic 
dysfunction, as measured by HRV in both time and frequency analyses. That is, SDNN, 
rMSSD, pNN50, and HF power values, reflective of parasympathetic under-activity, will 
be lower; and, LF power and LF/HF ratio, reflective of sympathetic activation, will be 
greater among short sleepers compared to long sleepers. 
Third, it is hypothesized that greater indices of autonomic dysfunction will predict 
obesity in youth, such that autonomic dysfunction (e.g., reduced HRV and 
parasympathetic activity and increased sympathetic activation) will be observed among 
heavier youth compared to lean youth. 
Finally, it is hypothesized that autonomic dysfunction will partially mediate the 
association between short sleep duration and obesity, even after controlling for potential 




Healthy children and their parents were recruited using flyers posted in the 
community and distributed to elementary and high schools affiliated with the English 
Montreal School Board. Letters were sent to principals who agreed to have materials 
distributed by classroom teachers. Exclusionary criteria included reported use of 
medications with cardiovascular effects, a history of cardiovascular complications, 
serious medical conditions, or psychopathology. A total of 122 children (50.8% girls) 
aged 8 to 17 years old (M= 12.81, SD = 2.19) participated in the study. There were 43 of 
families that participated and a total of 31 siblings. Parents were aged 30 to 65 years (M 
= 45.44, SD = 7.3) and were predominately mothers (78.9%). The institutional review 
board of Concordia University approved the study procedure (UH2005-077-2). 
Measures 
As part of the larger Healthy Heart Project, children and their parents completed 
measures assessing smoking, sedentary behavior, physical activity, culture, stressful life 
events, and diet. Parents also completed a general health and cardiovascular health 
history form for themselves and for their child(ren). Only the measures and procedures 
relevant to my thesis are described below. 
Anthropometric Data. Trained research assistants measured children's waist and 
hip circumference, height, and weight. All anthropometric measures were taken while 
the children were dressed in light clothing. While the children were standing, waist 
circumference was measured at the narrowest part of the body, midway between the 
lowest rib cage and the iliac crest, with a standard measuring tape. Hip circumference 
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was measured at the widest part of the body, over the buttocks with a standard measuring 
tape. Height was measured using a standard stadiometer, at maximal breath with shoes 
off. Waist and hip circumferences and height were measured in duplicate, to the nearest 
0.1 cm by two trained research assistants; the average of the two measurements was used. 
Weight and percent body fat were measured with a bioelectrical impedance scale 
(Tanita Body Composition Analyzer BF-350). BMI was calculated based on the formula 
weight (m)/height squared (m ). BMI percentiles were determined using the growth 
charts published by the U.S. Centers for Disease Control and Prevention (2000) which 
plot BMI with respect to age and sex (Ogden et al., 2002). 
Pubertal Stage. Pubertal status was determined based on the validated parent-
and self-report Growing and Changing Questionnaire ("Avon Longitudinal Study of 
Parents and Children" [ALSPAC], 2006) adapted from the Tanner questionnaire 
(Marshall & Tanner, 1969). There are five Tanner stages from prepubertal (PI) to 
complete sexual maturity (P5). The intermediate stages (P2, P3, P4) reflect progressive 
changes of external genitalia and pubic hair. Girls rated their pubertal stage based on a 
series of five standard illustrations with descriptive text on breast size and shape as well 
as pubic hair distribution. In addition, for girls, the age and date of their first period and 
the length of menstruation cycle were assessed. 
Boys rated their pubertal stage based on a series of five standard illustrations with 
descriptive text on the size and shape of the scrotum, testes, and penis, as well as on 
pubic hair distribution. For boys, changes in voice and hair growth in armpits were also 
assessed. A sixth response option was provided for participants who did not know. 
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Consistent with ethical guidelines, participants were given the option of refusing to 
answer any questions they did not want to. 
Compared to the gold standard of determining pubertal status through invasive 
assessments by pediatricians, this method was deemed most suitable and practical. The 
Tanner questionnaire has demonstrated moderate kappa coefficient agreement and thus 
the Growing and Changing questionnaire ("ALSPAC", 2006) was used. The reliability 
for breast or penis Tanner staging was 0.48 (95% CI: 0.31 - 0.64) between self-report 
Tanner ratings and clinical pediatric physician ratings (Taylor, Whincup, Hindmarsh, 
Lampe, Odoki, & Cook, 2001). A kappa coefficient agreement of 0.67 (95% CI: 0.49 -
0.87) was found for pubic hair development in boys and girls using the Tanner 
questionnaire and physician ratings (Taylor et al., 2001). 
Ambulatory Physiological Recordings. The LifeShirt (Vivometrics®) is an 
ambulatory monitor worn by children for 24-hours. The LifeShirt has received approval 
from Health Canada to measure continuous electrocardiogram (ECG), respiratory 
patterns (pulse oximetry), posture, and electroencephalogram (EEG). The LifeShirt is a 
noninvasive shirt worn underneath the children's clothes in their natural environment at 
home and school, thereby permitting ecologically valid measures of physiological 
parameters with minimal inconvenience. The LifeShirt system is made from a 
comfortable CoolMax garment embedded with two calibrated respiratory inductive 
plethysmography bands that measured changes in lung volume. 
Heart rate variability (HRV). HRV was derived from the ambulatory ECG 
LifeShirt recorder that the children wore while sleeping in their own bed at home. The 
ambulatory monitor is a 3-lead, single channel ECG used to measure heart rate from 
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which HRV can be derived. HRV indices were derived in two ways: by time domain 
analysis and by frequency (power spectral) domain analysis sampled at 200 Hz. Time-
and frequency-domain analyses were calculated from continuous ECG recordings during 
the children's sleep period. 
Time Domain Analysis. HRV time domain analysis quantified the successive 
normal R-R intervals recorded over the children's sleep period. Time domain variables 
include standard deviation of normal R-R intervals (SDNN) and the square root mean 
difference of successive R-R intervals (rMSSD). rMMSD is a measure of 
parasympathetic nervous system activity and is inversely correlated with the 
sympathovagal LF/HF ratio (Berntson et al., 1997). The pNN50 is the average number of 
times per hour in which the difference in successive R-R intervals are greater than 50 ms. 
All time domain indices were calculated in ms, excluding the pNN50 which was 
calculated as a percentage (Berntson et al., 1997). 
Frequency Domain Analysis. Given that HRV is composed of various 
frequencies, Fast Fourier transformation of R-R interval oscillations isolated two major 
frequency components: low frequency (LF, 0.04-0.15 Hz) and high frequency (HF, >0.15 
Hz) (Malliani, Pagani, Lombardi, & Cerutti, 1991). LF/HF ratio was also derived as an 
indicator of sympathovagal balance. 
Data Reduction 
Artifacts are waves, or groups of waves, which are not due to electrical activity 
but are produced as a result of technical problems, participant movement, or 
environmental disturbances. Even ECG artifacts as short as 2 minutes in duration have 
been shown to increase error in measuring HRV (Berntson & Stowell, 1998; Xia et al., 
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1993). Artifacts were identified and removed in the ECG waveform on the R-Waves and 
R-R Interval periods using the VivoLogic Software (VivoMetrics ®) and verified by 
visual inspection from a qualified trained professional. Based on VivoLogic Software, 
linear interpolation algorithms assigned cutoff values to successive R-R intervals so that 
any R-R values that fell above or below the cutoff values were removed. 
Premature contractions and irregular heart beats were also identified and removed 
from the data based on VivoLogic Software algorithms and verified by visual inspection 
from a qualified trained professional. The VivoLogic algorithm was based on three rules; 
first the order of intervals should be normal. Second, the difference between the large 
interval and the smaller interval must exceed 100 ms. Third, the sum of the large interval 
and the smaller interval should be within 10% of the sum of the previous and following 
normal intervals. Finally, the value of the previous normal interval should be within 20% 
of the value of the following normal interval. 
Subjective Sleep Measures 
Perceived Sleep Quality. Children rated their sleep quality on a scale of 1 to 10 
(l=very bad to 10=very good) twice; once for their typical night's sleep and again for the 
night they completed the sleep study. 
Sleep Duration. Children reported their usual wake and sleep times for school 
nights (Sunday through Thursday) and weekend nights (Friday and Saturday). Parents 
also reported their child's usual wake and sleep times on school and weekend nights. 
Sleep duration for school and weekend were calculated as the difference between parent-
and self-report sleep and wake times. Hence, four independent sleep duration measures 
were derived (school and weekends based on parent and self-reports). 
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Children's Sleep Habits Questionnaire (CSHQ). Parents completed the CSHQ 
(Owens et al., 2000). This questionnaire is used to evaluate children's sleep patterns over 
a one week interval and includes 43 questions to assess sleep problems such as difficulty 
in initiating and maintaining sleep, napping, and daytime sleepiness. Each question was 
rated on a 3-point scale that described the frequency (rarely, sometimes, and usually) of 
the sleep problems. For example, "in the last week, my child is ready to go to bed at 
bedtime". Scores for each item were summed to produce a total score that ranged from 0 
to 135. A score of 41 or above is considered to be indicative of more sleep-related 
problems, poor sleep quality, and more daytime sleepiness. The CSHQ has demonstrated 
test-retest reliability, validity, and internal consistency (Cronbach's alpha community 
sample = 0.68, clinical sample = 0.78; Owens et al., 2000). 
Pediatric Daytime Sleepiness Scale (PDSS). The PDSS (Drake et al., 2003) is a 
scale for pediatric populations to assess daytime sleepiness. Although the PDSS scale 
has not been validated using objective measures, it demonstrates acceptable reported 
levels of internal consistency (Cronbach's alpha =.81) and split-half reliability 
(Cronbach's alpha =.80) among middle-school aged children. Eight self-rated questions 
assessed daytime sleepiness and alertness in children based on the frequency (never, 
seldom, sometimes, frequently, always) of reporting, for example, "how often do you get 
sleepy or drowsy while doing your homework?". Each question was answered on a 0 to 
4 scale, and summed to calculate a global daytime sleepiness score. Total scores ranged 
from 0 to 32. A total score of 20 or more reflected a very "sleepy" child. The PDSS 
score was used as a subjective indicator of daytime sleepiness in children. 
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Objective Sleep Measures 
In-Home Sleep Study. Each child underwent a full-night sleep study in their own 
home with the LifeShirt BioSomnia Electroencephalogram (EEG) Device (VivoMetrics 
®) in combination with a horizontal electrooculogram (EOG). The BioSomnia EEG 
device measured changes in the duration and amplitude of electrical activity in the brain 
to identify distinct brainwave frequencies and was used to determine sleep stages within 
NREM and REM sleep. The EOG records electrical activity of eye movements and was 
used to determine slow and rapid eye movements. The sleep study included a singe 
channel EEG (FPz, Al, ground), as well as one EOG electrode on the right temple, with a 
sampling frequency of 200 Hz per channel. 
EEG has specific frequency bands including alpha (8-12 Hz), theta (3.5 to 7.5Hz), 
and delta (0.1-3 Hz) associated with specific sleep stages. Digital sleep data were stored 
for later analysis. Sleep staging and arousals were scored in 30-second segments 
(epochs) based on Rechtschaffen and Kales criteria (1968; adapted by VivoLogic 
software) as well as with visual detection by a qualified trained sleep technician. Sleep 
stages included wake, NREM (stage 1, stage 2, stage, 3, and stage 4) and REM for each 
epoch. 
Sleep Stage Criteria & Detection 
Stage Wake. Wake stage is the wakefulness state. It is defined by alpha activity 
and or low voltage and mixed frequency EEG. Alpha is associated with being alert 
(while eyes are closed) and with relaxation (deep breathing). Alpha distribution is 
typically localized and is mainly detected during the wake stage. The transition from 
wakefulness to Stage 1 is defined by a reduction in the amount, amplitude, and frequency 
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of alpha activity. Theta is slow brainwave activity and represents the transition between 
wakefulness and sleep states. Its distribution can generally be either diffused or localized 
to one side of the brain (Rechtschaffen & Kales, 1968). 
Stage 1. Stage 1 lasts from 1 to 7 min and occurs during the earlier portion of 
the stage. Stage 1 is characterized by the presence of slow eye movement, a moderately 
low voltage, mixed frequency EEG (alpha) activity ranging from 2 to 7 cycles per second 
(cps), and vertex sharp waves (Rechtschaffen & Kales, 1968). 
Stage 2. Stage 2 is defined by the presence of sleep spindles that must be present 
for at least half a second. In addition, the presence of K complexes (EEG waveforms 
with a negative sharp wave followed by a positive wave) must be present for over half a 
second (Rechtschaffen & Kales, 1968). 
Stage 3. This stage is defined by delta waves of 2cps or slower which are present 
for at least 20% but not more than 50% of the epoch (Rechtschaffen & Kales, 1968). 
Delta, the highest amplitude and the lowest brainwave frequency, is associated with 
diminished arousal levels and relaxed states (Rechtschaffen & Kales, 1968). Delta can be 
detected during NREM sleep stages 3 and 4 (deep or slow wave sleep). Its distribution is 
typically widespread and dispersed. Sleep spindles may or may not be present in this 
stage. 
Stage 4. This stage is defined by delta waves of 2cps or slower which are present 
for more than 50% of the epoch. Stage 4 is predominately composed of delta (slow 
wave) activity high in amplitude (Rechtschaffen & Kales, 1968). Sleep spindles may or 
may not be present in Stage 4. In general, during NREM sleep HRV is elevated and or is 
stable compared to wakefulness and REM sleep (Goldsmith et al., 2006). 
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REM. This stage is defined by the simultaneous presence of moderately low 
voltage, mixed EEG activity ("saw-tooth" waves), and episodic rapid eye movements. 
REM is similar to Wake (but the frequency is approximately 1 -2 cps slower) and to Stage 
1 (but no vertex sharp waves are present). No sleep spindles or K complexes are present 
during REM (Johnson, Lubin, Naitoh, Nute, & Austin, 1969). 
From these recordings, standard sleep measures included: 1) sleep period time, 
which includes only the time spent in light NREM, SWS, and in REM, 2) total sleep 
time, which includes all sleep stages and arousals, 3) sleep efficiency, the percentage of 
time in bed spent asleep, 4) sleep latency (the amount of time it takes to fall asleep, in 
minutes), 5) fragmented sleep (the number of awakenings lasting at least 15 seconds), 6) 
the intermittent arousal index (sum of duration of all awakenings between sleep onset and 
sleep offset) and the 7) micro-arousal index (the average number of arousals per hour of 
sleep). In addition, the percent of time spent in light NREM, SWS, and REM sleep were 
derived. The LifeShirt has a sensitivity of 0.83 and specificity of 0.87 with traditional 
polysomnograph (Orr & Goodrich, 2003). 
Procedure 
A telephone screening interview was conducted to ensure children met 
inclusionary criteria (e.g., no serious psychopathology) and two sessions were scheduled 
at the laboratory, three days apart. During the first session, the study protocol was 
described and explained to parents and their children. If the parents and children agreed 
to participate, parental informed consent and child assent were obtained. Next, parents 
and children were separated into different rooms and each completed a set of 
questionnaires; this prevented parents and children from obtaining answers from each 
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other on their respective questionnaires. After the children completed their 
questionnaires, they were brought into the medical room where two trained research 
assistants completed a finger prick blood test (i.e., cholesterol levels) and collected 
anthropometric measurements (i.e., waist and hip circumference and height and weight). 
Next, children were fitted with the ambulatory monitor (Vivometrics® LifeShirt) 
by the research assistants. Three ECG electrodes were placed in a Lead II configuration: 
two electrodes (active electrodes) were placed one-inch under each of the shoulders and 
one electrode was placed on the left side of the child's abdomen (ground electrode). 
Instructions for operating the LifeShirt were explained and troubleshooting tips were 
provided to both the parent and child. Also at this time, the research assistants provided 
instructions to parents and children on the sleep study. In addition, instruction sheets and 
a contact phone number were provided in the event that the parent and or child had 
questions during the 24 hour monitoring session. 
The sleep study took place at the child's home. Before the child went to sleep, the 
parent or child attached an auxiliary EEG device (LifeShirt Oxford BioSomnia) to the 
LifeShirt. The parent or child then placed three EEG electrodes directly onto the skin of 
the child's forehead (FPz), left mastoid (Al referent), and nape of the neck (ground 
electrode), as well as one EOG electrode on the child's right temple. This 4-lead 
configuration permitted minimally invasive polysomnograph (PSG) data collection of 
brain wave activity and eye movement to be conducted while the child slept in his or her 
own bed. In addition, a finger clip (pulse oximeter) was placed on the child's index 
finger to measure blood oxygen saturation levels throughout the night. 
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When the child awoke, the sleep study was considered complete. Upon 
awakening from the sleep study, the parent or child removed the EEG and EOG 
electrodes and the child continued wearing the LifeShirt for the remainder of the 24 hours 
during a normal school day. Upon completing the 24 hours, the LifeShirt was removed 
by the parent or child. During the second session, the parent and child returned the 
LifeShirt equipment and completed a feedback form to report their experience with the 
LifeShirt and the sleep study. 
Lastly, as compensation for their time, participants received $60, a feedback sheet 
about their own heart health, and an educational healthy lifestyle packet. 
Data Preparation 
ECG data captured during the sleep study were analyzed with VivoLogic software 
and by visual inspection. VivoLogic was used to calculate frequency- (LF, HF, LF/HF 
ratio, LFnu, and HFnu) and time- (SDNN, rMSSD, and pNN50) domain indices for every 
30-second epoch during sleep. Thirty-second epochs were chosen to permit matching 
HRV data with the appropriate sleep stage (e.g., Stages 1-4) scored using the 
Rechtschaffen and Kales (1968) criteria. For each individual participant, VivoLogic 
produced a "sleep stage" excel file output organized by 30-second intervals and their 
respective sleep stages scored from Stages 1-4 and REM. Next, for each participant, 
VivoLogic produced a "HRV" excel file output, again organized by 30-second epochs 
that coincided with the sleep output. Frequency domain variables were analyzed with 
Fast Fourier Transform at 128 Hz with a resample rate of 10. The HRV output was 
merged with the sleep output to created one master file for each participant. The number 
of 30-second intervals in the output ranged from 679-1605 across participants. 
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Data Cleaning 
HRV data identified as artifacts by VivoLogic algorithms were immediately 
removed from the master file for each participant. From the 57 participant files, 43 
(75%) did not have any artifacts identified by VivoLogic software, thus no intervals were 
removed; 9 files (16%) had <1% of the data identified as artifacts (e.g., from 1253 to 
1250 intervals); 2 files (4%) had 2% of data identified as artifacts (e.g., from 1159 to 
1147 intervals); 2 files (4%) had - 8 % of data identified as artifact (e.g., from 1090 to 
1018 intervals); and, one file had 15% of data identified as artifact (e.g., from 992 to 
839). 
The mean HRV values for each frequency- and time-domain variables were 
calculated. HRV values that were above or below four standard deviations from the 
mean were visually inspected in the raw data screen, cleaned, and replaced with the 
average HRV value for the respective sleep stage for each individual. Following the 
removal of artifacts and outliers, HRV variables in Stages 1 and 2 were aggregated to 
represent light NREM sleep, while Stages 3 and 4 were aggregated to represent SWS. 
REM sleep had its own HRV values. 
Statistical Analyses 
Assumptions of multivariate normality were met, such that all univariate 
distributions were normal and all bivariate scatterplots were linear and homoscedastic. 
Outliers and missing data were replaced with the mean for that particular variable. All 
analyses were cross-sectional and performed using SPSS 15.0. A/?-value of <0.05 was 
considered significant for all analyses. 
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Structural equation modeling (SEM), using Lisrel Version 8.8 (Joreskog & 
Sorbom, 2001), was used to test the mediation models. SEM is a complete approach to 
modeling multiple interrelated observations simultaneously (Kline, 1998). In the present 
study, the maximum likelihood estimation method of SEM was used and the listwise 
deletion method was used to deal with missing and or incomplete data. Manifest 
(observed) variables and latent (unobserved) variables were included into the models and 
tested to see if the models explained the data (goodness of fit). The following indices 
were used to assess the goodness of fit of the models: 1) Comparative Fit Index (CFI 
>.90), 2) Non-Normed Fit Index (NNFI; >.90), 3) Root Mean Square Error of 
Approximation (RMSEA >.05 to .08), and 4) Goodness of Fit Index (GFI >.90; Bentler, 
1990). Chi-square statistic, degrees of freedom, and R were used to determine mediation 
in the models. 
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RESULTS 
Sample Characteristics. The characteristics of the parents and children who 
participated in the study are outlined in Table 1. The majority of the parents were 
mothers (78.9%) averaging 45.4 years (SD = 7.3), were married (68.5%), obtained an 
undergraduate degree (37.8%), and reported a household income of $60,000 to $69,000 
(14.6%). There were 122 children (50.8% female), aged 8 to 17 years (M = 12.81, SD = 
2.19) who participated. On average, youth's waist circumference was 73.14 cm (SD = 
9.52), hip circumference was 91.34 cm (SD = 10.68), weight was 118.66 lbs (SD = 
30.53), BMI was 21 kg/m2 (SD = 3.97), percent body fat was 22% (SD = 9.62), and BMI 
percentile was 63.91 (SD = 25.07; see Table 2). Consistent with other North American 
population studies, our sample consisted of 8% obese children and 18% overweight 
children based on CDC BMI growth charts (CDC, 2000). 
Pubertal Status. Based on child-report, pubertal status for girls' breast and hair 
development was Tanner stage 3.25 (SD = 1.46) and 3.27 (SD = 1.72), respectively. On 
average, 80.3% endorsed having hair in armpits and 66.1% have begun their menstrual 
periods (see Table 3). Pubertal status for boys' penis and hair development was Tanner 
stage 2.83 (SD = 1.62) and 3.02 (SD = 1.52), respectively. On average, 62.3% endorsed 
having hair in armpits and 29.5% report changes in their voice (see Table 4). 
Subjective Sleep Measures. Children reported sleeping an average of 8 h 56 min 
(SD = 59 min) on school nights and 9 h 57 min (SD = 1 h 17 min) on weekend nights. 
Based on child-report, the mean Pediatric Daytime Sleepiness Score was 13.96 (SD = 5.5; 
see Table 5). Parents reported their children sleep an average of 9 h 07 min (SD = 56 
min) on school nights and 10 h 09 min (SD = 1 h 09 min) on weekend nights. The 
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intraclass correlations (ICC) between child- and parent-report of sleep duration on school 
nights was 0.70 (CI 95% 0.59 - 0.78, p <.001); on weekend nights was 0.42 (CI 95% 0.26 
- 0.56, p <.001). Based on parent-report, the mean score on the CSHQ total sleep 
disturbance score was 40.51 (SD = 5.9); the remaining subscales are shown in Table 5. 
From the original 122 children recruited for this study, 82 (66.7%) completed the 
in-home sleep study; the remaining 33.3% did not participate in the in-home sleep study 
either because the sleep recorder was not yet acquired so they had no opportunity to 
complete it (n — 35) or because they refused to complete the sleep study (n = 5). One-
way ANOVA statistics showed no significant differences between youth who did and did 
not complete the sleep study based on age (F(i} 121) = 0.57, p = .49), waist circumference 
(F(i, 121) = 0.09, p = .77), or child-report of sleep duration on school nights (F(i, 121) = 
0.04, p = .85). These groups also did not differ on pubertal status [Girls: breast 
development (F (i; 60) = 0.11, p = .74); hair growth (F (i; 59) = 0.11, p = .74); the start of 
menstruation (F(i, 6i)= 0.01,p = .93); Boys: pubertal penis development (F(i, 59) = 0.35, p 
= .56); hair growth (F (i, 59) = 0.01, p = .92)]. Only one female participant reported 
menstruating on the night of her sleep study. 
Of the 82 children who completed the sleep study, 24 (30%) experienced 
problems with the sleep recorder (e.g., sleep recorder did not work, batteries died, sensor 
fell off and lost EEG and/or ECG signal for more than 60 consecutive minutes during 
sleep) leaving 57 (70%) participants with complete and sufficient EEG and ECG data, 
defined as more than 5 hours of sleep with clean EEG and ECG signals. No differences 
were found in perceived sleep quality for typical nights (M= 6.75, SD = 2) compared to 
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the in-home sleep study (M= 6.66, SD = 2.32; F(i, 120) = 0.86, p = .36) for those who did 
and did not complete the sleep study. 
Objective Sleep Measures. Table 6 summarizes the data for all in-home sleep 
study parameters. On average, the sleep period time was 517.03 min (SD = 77.75) and 
the total sleep time was 467.28 min (SD = 100.90). The average number of awakenings 
lasting at least 15 seconds was 50.91 (SD = 30.22). Children spent 23.40% (SD = 8.17) 
in light NREM, 20.19% (SD = 8.57) in SWS, and 45.07% (SD = 17.69) in REM sleep. 
The mean sleep efficiency was 89.37% (SD = 11.39) and sleep latency was 1.97 min (SD 
= 2.83). No sex differences were found for any of these objective sleep parameters (e.g., 
sleep period time, total sleep time, etc.). 
HRV Measures. The mean values for HRV measures during light NREM, SWS, 
and REM sleep are summarized in Table 7. In general, frequency- (LF, HF) and time-
domain (SDNN, rMSSD, pNN50) HRV indices were highest during REM sleep and 
lowest during SWS. Table 8 shows differences in HRV variables in normal-weight, 
overweight, and obese children during light NREM, SWS, and REM sleep. In general, 
normal-weight youth had the highest indices of parasympathetic activity compared to 
overweight and obese youth. 
Obesity Constructs. Inter-correlations among obesity variables indicated that 
waist circumference (ravg = 0.80, p<.00l), hip circumference (rw% = 0.80, /?<.001), and 
BMI (ravg = 0.81, p<001) were the strongest indices associated with all of the obesity 
variables. Percent body fat (ravg = 0.64, /?<.001) corresponded the least with the 
remaining obesity variables (see Table 9). 
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Subjective Sleep Constructs. Inter-correlations among subjective sleep variables 
indicated that child-report perceived sleep quality (ravg - 0.25, /K.05), child-report sleep 
duration (ravg = 0.19, p<.05), and child-report daytime sleepiness (ravg = 0.26, p<.05) 
were highly inter-correlated with other subjective sleep measures. 
Objective Sleep Constructs. Inter-correlations among objective sleep variables 
indicated that fragmented sleep (ravg = 0.36, p<.05), time spent in REM (ravg = 0.33, 
p<.05) and sleep efficiency (ravg — 0.36,/K.01) were found to be highly related with other 
objective sleep variables (see Table 11). Some subjective sleep measures were also 
found to correlate with objective sleep measures. Child-report sleep duration on school 
nights only was negatively correlated with sleep efficiency (r = -0.31, p<.05) and time 
spent in REM sleep (r = -0.28, p<.05; Table 12). Parent-report sleep duration on school 
nights was correlated with time spent in light NREM (r = 0.30, p<.05); as well, 
fragmented sleep was positively associated with night awakenings (r = 0.27, p<.05; Table 
13). 
Autonomic Dysfunction Constructs. Inter-correlations among the frequency-
domain HRV variables indicated that HF (ravg = 0.69, p<.0\) and the time-domain HRV 
variables SDNN (ravg = 0.53, p<.0\), rMSSD (ravg = 0.72, /?<01), and pNN50 (ravg = 
0.67, p<.0l) were the HRV variables best representing parasympathetic activity and 
together were negatively correlated with the sympathovagal balance LF/HF ratio index 
( r ^ = -0.54,/K.01; Table 14). 
Age Effects. Partial correlations were computed to assess the relation between 
obesity measures and sleep measures while controlling for age. On average, a negative 
linear relation was found between obesity measures (waist and hip circumference, 
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weight, BMI, percent body fat, BMI percentile) with child-report sleep quality (ravg = -
0.33, p<.05) and parent-report on CSHQ sleep disturbance (ravg = -0.38, p<05). And 
inversely, a positive association between obesity measures and child-report daytime 
sleepiness (ravg = 0.19, /?=n.s) and parent-report on CSHQ daytime sleepiness (ravg = 
0.33, p<.05) was found (see Table 15). Obesity measures were also significantly 
correlated with objective sleep measures. As shown in Table 16, the majority of the 
objective sleep measures were inversely correlated with obesity measures. These results 
support the hypothesis that sleep (shorter sleep duration and poorer sleep quality) is 
negatively associated with obesity. 
While controlling for age, partial correlations showed that the time spent in SWS 
was positively correlated with LF/HF ratio (r - 0.35, p<.05) and LFnu (r - 0.37,/K.05), 
and was negatively correlated with HFnu (r = -0.30, p<.05; see Table 17). Sleep 
efficiency was negatively associated with LF (r = -0.29, p<.05), HF (r = -0.28, p<.05), 
and SDNN (r = -0.26, p<.05) during SWS. Fragmented sleep was negatively correlated 
with LF/HF ratio (r = -0.28, p<.05) and LFnu (r = -0.25,/K.05), and positively correlated 
with HFnu (r = 0.27, /K.05). These correlations during SWS are presented in Table 18; 
during REM are in Table 19. Although there are significant relations among sleep and 
HRV measures, these results were not in the hypothesized direction. 
Partial correlations, while controlling for age, showed that HRV variables: LF, 
SDNN, rMSSD, and pNN50 in light NREM, SWS, and REM sleep were significantly 
negatively correlated with obesity measures (see Tables 20-22). No significant 
correlations were found for LFnu, HFnu, or LF/HF ratio with the obesity measures. 
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These results partially support the hypothesis that autonomic dysfunction is associated 
with obesity. 
Hypothesized Model Testing 
Three latent variables were created: obesity, autonomic dysfunction, and sleep. 
Although partial correlations showed strong associations between frequency-domain 
HRV variables and the sleep and obesity measures, only SDNN, rMSSD, and pNN50 
variables were included as manifest variables. Because SEM is extremely sensitive to 
sample size and multicollinearity among items, our small sample size precluded analyses 
with the frequency-domain variables. Thus, three models were tested for partial 
mediation while controlling for age. The latent variables sleep and obesity made up the 
base model. 
Base Model. The latent variable obesity was made up of three manifest variables 
that were found to best represent the construct: waist circumference, hip circumference, 
and BMI. In the measurement model, waist circumference had a loading of 0.90, hip 
circumference had a loading of 0.97, and BMI had a loading of 0.88. Goodness of fit 
indices suggest the measurement model was a good fit with the data (CFI = 0.99, NNFI = 
0.99, RMSEA = 0.00, GFI = 0.99). The latent variable sleep was made up of three 
manifest variables that were found to best capture the construct: sleep efficiency, 
fragmented sleep, and time spent in REM. In the measurement model, sleep efficiency 
had a loading of 0.70, fragmented sleep had a loading of 0.55, and time spent in REM 
had a loading of 0.97. The measurement model showed a good fit (CFI = 0.88, NNFI = 
0.65, RMSEA = 0.21, GFI = 0.94). Although time spent in SWS and REM were also 
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found to be highly related with other indices, due to multicollinearity, these manifest 
variables could not be included in the SEM models. 
The structural equation revealed a moderate association between sleep and obesity 
with an R2 - 0.14 (x2 = 15.75, # = 1 0 ) . This path model was a good fit with the data 
(CFI = 0.94, NNFI = 0.92, RMSEA = 0.10, GFI = 0.93; see Figure 1). 
Model 1. In the first model, the latent variable autonomic dysfunction was 
composed of manifest variables: SDNN values during light NREM, SWS, and REM 
sleep. SDNN during light NREM had a factor loading of 0.93, during SWS had a loading 
of 0.95, and during REM sleep had a loading of 0.99. The measurement model showed 
strong goodness of fit indices (CFI = 1.00, NNFI = 1.02, RMSEA = 0.00, GFI = 0.99). 
When a path from sleep to autonomic dysfunction was added into the model, results 
showed 3% of the variance in autonomic dysfunction was explained by sleep (x2 = 19.56, 
df= 13) and goodness of fit indices were high (CFI = 0.94, NNFI = 0.91, RMSEA = 0.09, 
GFI = 0.91). When a path from autonomic dysfunction to obesity was added, an R2 = 
0.15 (x2 = 10.34, # = 1 0 ) was found. Goodness of fit indices were high (CFI = 0.99, 
NNFI = 0.99, RMSEA = 0.02, GFI = 0.95). When all three paths between latent 
variables were included, 25% of the variance in obesity was explained by both sleep and 
autonomic dysfunction (x2 = 37.70, df- 28) with an acceptable fit with the data (CFI = 
0.96, NNFI = 0.94, RMSEA = 0.07, GFI = 0.88; see Figure 2). 
Model 2. A second model was run with autonomic dysfunction based on the 
rMSSD manifest variables for light NREM (factor loading of 0.99), SWS (factor loading 
of 0.96), and REM sleep (factor loading of 96). The measurement model had a good fit 
(CFI = 0.98, NNFI = 1.00, RMSEA = 0.00, GFI = 0.98). The path from sleep to 
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autonomic dysfunction did not produce a significant association (R2 = 0.03, x2 = 14.65, df 
= 13). The path from autonomic dysfunction to obesity produced an R2 = 0.12 (x2 = 4.82, 
df= 10; CFI = 0.99, NNFI = 1.03, RMSEA = 0.00, GFI = 0.98). When all paths were 
added, 24% (x2 = 27.00, # = 28) of the variance in obesity was accounted for (CFI = 
0.99, NNFI = 0.98, RMSEA = 0.00, GFI = 0.91; see Figure 3). 
Model 3. A third model was run with autonomic dysfunction based on the pNN50 
manifest variables from light NREM (factor loading of 0.96), SWS (factor loading of 
0.99), and REM sleep (factor loading of 0.95). The measurement model had a good fit 
(CFI = 1.00, NNFI = 1.00, RMSEA = 0.00, GFI = 0.99). The path from sleep to 
autonomic dysfunction did not reveal a significant association (R2 = 0.00, x2 = 21.01, df= 
13) even though data showed modest fit with the model (CFI = 0.95, NNFI = 0.92, 
RMSEA = 0.10, GFI = 0.90). The path from autonomic dysfunction to obesity produced 
a significant association and good fit (R2 = 0.11, x2 = 13.92, df= 10; CFI = 0.98, NNFI = 
0.96, RMSEA = 0.08, GFI = 0.93). Lastly, when all paths were added, sleep and 
autonomic dysfunction explained 25% of the variance (R2 = 0.25, x2 = 38.85, df= 28; 
CFI = 0.96, NNFI = 0.94, RMSEA = 0.08, GFI = 0.88; see Figure 4). 
Post-Hoc Exploratory Analyses. Due to issues with multicollinearity, sample 
size, and power, post-hoc exploratory analyses were conducted with multiple linear 
regression to evaluate the frequency-domain HRV variables while controlling for age. In 
parallel with the SEM analyses, a base model consisting of time spent in REM and BMI 
was first tested. Time spent in REM significantly predicted BMI (F(i; 54) = 4.91, p = .03) 
and explained 8% of its variance. When LF/HF ratio during REM was added to the 
model, time spent in REM did not significantly predict LF/HF ratio (F (i, 54) = 0.30, p = 
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.58; R2 = 0.01); and LF/HF ratio did not significantly predict BMI (F(i,54) = 0.01, p = .91; 
R2 = 0.00). These multiple regression exploratory models were repeated for LF/HF ratio 
during SWS and light NREM (data not shown) and similar results were found; these 
results do not support the mediation hypothesis. 
These multiple regression exploratory models were repeated for LF and HF 
during light NREM, SWS, and REM. Although LF during light NREM (F(1, 54) = 6.95, p 
= .01; R2 = 0.11), SWS (F(1, 54) =5.03, p=.02; R2 = 0.09), and REM ( F a 54) = 7.21, p = 
.01; R =0.11) predicted BMI, time spent in REM did not significantly predict LF in light 
NREM (F(i,54) = 1.69,p = .19; R2= 0.03), SWS (F(i,54) = 1-84,p = .18; R2 = 0.03), or in 
REM (F(i, 54) = 0.64, p = .43; R2 = 0.01). When sleep and LF during light NREM were 
added into the model, again both contributed to BMI (F(i, 53) = 4.69, p = .006; R2= 0.17), 
but each of their variance decreased by 2% (LF: R2 = 0.09, j?=02; REM: R2 = 0.06, 
p=.06). Similar results were observed for LF during SWS (LF: R2 = 0.07,/?=.06; REM: 
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R = 0.06, p=.06). Finally when time spent in REM and LF in REM were simultaneously 
added to the model they individually contributed to predicting BMI (LF: R2 = 0.11, 
p=.02; REM: R = 0.07, p=.Q4) and suggested partial mediation as the beta coefficient for 
time spent in REM decreased by 1%. These results suggest only some support for partial 
mediation. 
When HF variables were included in the models, HF in light NREM (F (i, 54) = 
6.86,p = .01; R2= 0.11), SWS ( F a , 54) = 7.38/? = .001; R2= 0.12), or in REM (Fa,54) = 
5.70, p = .02; R2 =0.10) significantly predicted BMI; however, time spent in REM did 
not significantly predict HF in light NREM (F(i, 54) = 0.81, p = .37; R2 = 0.02), SWS (F(1, 
54) = 0.92, p = .34; R2 = 0.02), or REM sleep ( F a , 54) = 1.19, p = .28; R2 = 0.02). When 
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sleep and HF during light NREM were added into the model, again both contributed to 
BMI, but each of their variance decreased by 1% (HF: R2 = 0.10,;?= 01; REM: R2 = 0.07, 
p=.05). Similar results were observed for HF during SWS (HF: R2 = 0.08,p=.03; REM: 
R = 0.07, p=.05). Finally, when time spent in REM and LF in REM were simultaneously 
added to the model they individually contributed to predicting BMI (HF: R =0.08, 
/?=.03; REM: R2 = 0.07, p=.05) and the variance attributed to time spent in REM 
decreased by 1% and the variance attributed to HF decreased by 3%. The results suggest 
only some support for partial mediation. However, the results are to be interpreted with 
caution due to possible suppression effects (see Discussion). 
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DISCUSSION 
The aim of the present study was to examine whether autonomic dysfunction, 
measured by HRV, mediated the relation between sleep and childhood obesity. 
Consistent with previous cross-sectional literature (cf. Beebe et al., 2007; Gupta et al., 
2002; Sekine et al., 2002; von Kries et al., 2002), our results demonstrate a clear 
association between short sleep duration, poor sleep quality, and more sleep complaints 
among youth with greater adiposity indices. Heavier youth reported overall poorer sleep 
quality, reduced sleep duration, and complained more of daytime sleepiness than their 
lean counterparts, even after controlling for age. Based on parent-report, heavier youth 
had shorter sleep durations and exhibited more sleep problems, including bedtime 
resistance, sleep disturbance, and daytime sleepiness compared to lean youth. 
Parent-reported sleep problems, such as sleep-onset delay, sleep anxiousness, and 
sleep-disordered breathing were less consistently associated with obesity. These 
differences may be attributable to the variation of observable symptoms; for example, 
most children in our sample reported that they slept alone in their own bedroom, which 
would make parent report on sleep-onset delay difficult; whereas, daytime sleepiness is a 
more "noticeable" sleep problem (Carskadon et al., 1999). 
Based on the in-home sleep PSG study, heavier youth had shorter sleep duration 
and sleep latency, they spent less time in light NREM and SWS, and they spent more 
time in REM sleep, than their lean counterparts. Previous studies suggest that the amount 
of delta waves and the time spent in SWS are heritable and stable individual traits 
(Franken & Tafti, 2003; Linkowski, 1999; Tan, Campbell, & Feinberg, 2001). 
Additionally, in mice, mutations in the circadian Clock gene lead to obesity (Turek et al., 
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2005). It is plausible that a clock gene encoding for these sleep parameters may also be 
involved in the development of obesity and other related diseases such as diabetes and 
insulin resistance within particular populations. 
Lean youth showed fewer, but longer micro-arousals compared to heavier youth 
who showed more, but shorter micro-arousals. Micro-arousals are more likely to occur 
during REM than in NREM sleep (Halasz, Terzano, Parrino, & Bodizs, 2004). Heavier 
youth spent a larger portion of sleep in REM which suggests that the sleep they did obtain 
was non-restorative (Halasz et al., 2004). In addition, micro-arousals are associated with 
daytime sleepiness (Sforza, Chapotot, Pigeau, Naitoh, & Buguet, 2004) which explains 
why heavier youth and their parents reported more daytime sleepiness symptoms. 
Similar to past research, an association between objective sleep measures and 
autonomic dysfunction was found. As expected, as the number of awakenings increased 
and as sleep efficiency decreased, LF (absolute, but not normalized) values increased 
indicative of greater arousals and fragmented sleep (Halasz et al., 2004). Unlike previous 
findings, greater time spent in SWS was associated with LFnu and LF/HF ratio, as well 
as reduced HFnu. Unexpectedly, we found that greater HF (absolute), a marker of 
parasympathetic activity, was also associated with markers of poor sleep quality (time 
spent in SWS), fragmented sleep, and greater sympathovagal balance during sleep. 
These findings were not consistent across all HRV indices, as no relation was observed 
between time-domain variables and objective sleep measures. These are counter-intuitive 
and may be attributable to other factors, such as the measurement technique or design 
(described below in limitations). 
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Using subjective sleep measures, an association between sleep and autonomic 
dysfunction was also observed. Poorer perceived sleep quality was associated with 
reduced rMSSD, pNN50, and HF (absolute and normalized) values as well as with 
greater LF/HF ratio and LFnu, suggesting that youth with reduced parasympathetic 
activity and increased sympathetic activity perceive their sleep as poor. Daytime 
sleepiness complaints were associated with reduced pNN50 values; sleep disturbance 
reported by parents was also related with reduced SDNN and HF (absolute) values during 
sleep. These results suggest that less restorative sleep is associated with reduced 
parasympathetic activity and autonomic dysfunction. 
Sloan and colleagues (2005) have demonstrated that psychosocial stressors (i.e., 
daily hassles, lower socioeconomic status, chronic stress, etc.) can dampen cardiac 
parasympathetic activity and increase risk of adverse health complications. Similarly, 
Hall and colleagues (2004) found that a speech stress task is related to significantly 
reduced parasympathetic activity and more fragmented sleep in stressed individuals 
compared to controls. Thus, given that daily stressors can impact both autonomic 
function and sleep, subjective sleep measures may provide a better indicator of overall 
sleep compared to one night with the sleep study. Although the in-home sleep provided 
detailed information on objective sleep measures that could not be assessed with 
questionnaires, these results highlight the importance of obtaining information from 
multiple sources. 
Similar to previous findings, youth with greater adiposity evidenced autonomic 
dysfunction. Throughout sleep, significantly dampened HRV was observed among 
heavier youth, with lower SDNN, rMSSD, and pNN50 values. Based on the frequency-
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domain variables (LF and HF), parasympathetic activity was also significantly reduced 
throughout sleep. These results are similar to other studies that computed HRV variables 
in absolute values (vs. normalized units; Nagai et al., 2003; 2004). 
Compared to studies using normalized HRV values (Kaufman et al., 2007; Rabbia 
et al., 2003), HFnu results were consistent, with lower values among heavier youth. 
However, LFnu values were also lower among heavier youth; in fact, healthy-weight 
youth had greater values. Given that there is evidence that the LF band of HRV is not 
exclusively associated with sympathetic activity, but also with parasympathetic activity 
(Berntson et al., 1997), these results suggest that youth with excess adiposity show 
reduced parasympathetic activity. There was, however, a non-significant trend indicating 
an elevated LF/HF ratio among heavier youth during sleep, which may suggest 
sympathetic activation. 
Rabbia and colleagues (2003) found that duration of obesity was related to 
autonomic dysfunction. Specifically, youth who were obese for a longer period showed a 
reduction in LFnu and LF/HF ratio, meaning an under-active sympathetic activation; 
whereas, recently obese youth (shorter duration) showed greater LFnu and LF/HF ratio 
values, indicating an over-active sympathetic drive and an under-active parasympathetic 
tone. In the present study, we did not control for duration of obesity and it is likely that 
our obese sample may have been obese for some time, which may partly explain our 
results. 
Inconsistent with our hypothesis, the results of this study do not fully support the 
mediation model that autonomic dysfunction is a potential pathophysiological mechanism 
underlying the association between objective sleep measures and obesity indices. 
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Objective sleep measures, such as fragmented sleep, sleep efficiency, and time spent in 
REM were directly related to obesity measures (BMI, waist and hip circumference). 
However, the relation between objective sleep measures and both time- and frequency-
domain HRV measures were not significant. It is plausible that the duration of sleep 
problems may affect autonomic dysfunction, such that the longer sleep problems are 
experienced, the more autonomic dysfunction occurs. Therefore, because objective 
measures are based on a single night of recording they did not tap into the frequency and 
severity of potential sleep problems. Nevertheless, while both autonomic dysfunction 
and sleep correlated with obesity, direct mediation was not supported. 
The results must be interpreted with caution as there is some evidence of 
statistical suppression. Unlike the mediation model which predicted that the association 
between sleep and childhood obesity would decrease after autonomic dysfunction was 
controlled for (i.e., added in the model), the results of the SEM models were opposite 
this, such that the addition of autonomic dysfunction increased the predictive validity 
(variance) in obesity attributed to sleep. Because sleep and HRV are two highly inter-
dependent variables, meaning that certain sleep stages naturally exhibit certain 
preponderance of the ANS parasympathetic or sympathetic activity than in other stages 
(i.e., REM sleep shows more sympathetic activation and less parasympathetic activation 
vs. NREM sleep), examining HRV in the context of time in REM inherently masks its 
effects. In other words, because youth with greater adiposity were observed to spend 
more time in REM sleep, this inherently means that they also have greater sympathetic 
activation and less parasympathetic activity than those spending more time in SWS. 
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These findings provide only some support the role of autonomic dysfunction in the 
association between sleep and obesity. 
Strengths 
There were several methodological strengths in the present study. First, our study 
included a sample that was representative of the general population, with prevalence rates 
of healthy-weight, overweight, and obese youth similar to population-based studies 
(Tremblay et al., 2002). Unlike previous studies that include samples of 10-13 years, the 
age range of our participants consisted of a wide age range (from 8-17 years). 
Second, unlike previous cross-sectional studies, we included multiple indicators 
of obesity, including body fatness (BMI), fat distribution (waist and hip circumference), 
and percent body fat, providing us with a more comprehensive measure of obesity. This 
study also included a comprehensive assessment of sleep with several sleep measures 
assessed subjectively from multiple informants (e.g., child and parent) and objectively 
with an in-home sleep study. This multi-model approach likely provides more valid and 
reliable measures of obesity and sleep. 
Third, this was the first study to have children and adolescents complete an 
ambulatory in-home sleep study while simultaneously measuring continuous ECG and 
EEG. The LifeShirt system, in conjunction with the BioSomnia sleep recorder, are 
advanced technological equipment that permit the collection of continuous physiological 
data with minimal intrusion. Distinct from formal sleep studies which are conducted in 
different settings (i.e., hospital or laboratory), our procedure and method allowed children 
and adolescents to complete a comprehensive sleep study in their natural environment. 
Studies have cross-validated in-home sleep studies against laboratory PSG (Ancoli-Isreal, 
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Kripke, Mason, & Messin, 1981; Redline, Tosteson, Boucher, & Millman, 1991) 
providing support that in-home sleep studies are ecologically valid. 
Fourth, due to the technology used, continuous HRV data was extrapolated and 
examined within various sleep stages. These stage-specific analyses provided important 
information and insight about autonomic function during sleep in youth. 
Lastly, unlike ANOVA and regression analyses, SEM analyses (conducted 
whenever possible) allowed for the simultaneous examination of latent variables made of 
several manifest variables. The use of this statistical method provided a means of 
maximizing the multi-modal data for sleep, obesity, and autonomic function obtained 
from our sample. Despite these methodological strengths, there were limitations which 
may have affected our results. 
Limitations and Recommendations 
One limitation of the present study was the way the ECG data was cleaned and 
prepared. HRV measures were aggregated to synchronize with specific sleep stages and 
thus coded into 30-second epochs. Typically, HRV measures are analyzed based on at 
least 5 minute recording periods (Berntson et al., 1997). Using shorter intervals to 
capture autonomic dysfunction masked subtleties in HRV and likely reduced our power 
to detect a relation between objective sleep measures and autonomic dysfunction. It 
would be optimal to have used software which analyzed HRV data at larger intervals to 
include greater power frequency bands within each sleep stage; unfortunately, this 
software does not yet exist. 
Second, because the early portion of sleep is mainly made up of NREM sleep, 
which is driven by the parasympathetic branch, and conversely, the later portion of sleep 
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is composed of REM sleep, which is dominated by the sympathetic activity, aggregating 
sleep stages together may have skewed or biased the results by assuming that sleep stages 
are homogenous. As example, it may not have been representative to aggregate REM 
from early sleep with REM from later sleep because although time spent in REM was 
controlled for, time effects were not. Clearly, given that both sleep (Laposky et al., 2008) 
and HRV (Massin, Maeyns, Withofs, Ravet, & Gerard, 2000) are influenced by circadian 
rhythms, this may be a potential drawback and should be considered in future studies. 
More complex statistical analyses should be applied to include time effects/order to 
control for this redundant variance in each unique variable. 
Third, in the present study we analyzed HRV during sleep; most studies deprive 
or restrict sleep in their participants for several days and investigate autonomic 
dysfunction the following days (cf. Spiegel et al., 1999; 2004; 2005). Compared to 
controls, narcoleptic patients exhibit similar autonomic function during sleep, however 
there are significant differences in autonomic function during wakefulness (before sleep) 
between the groups (Ferini-Strambi et al., 1997), suggesting that autonomic function 
impairment may be influenced by both sleep and wake cycles. It is therefore 
recommended that both sleep and wake cycles be investigated; however, this would be 
difficult as it becomes more invasive and intrusive for participants (Katz et al., 2002; 
Scholle et al., 2003). 
The fourth weakness in this study was that healthy children underwent the in-
home sleep study for one night under normal sleeping conditions. The in-home sleep 
study was performed only once and results may have been influenced by the first night 
effect. The first night effect has been observed in children and adolescents, which results 
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in reduced sleep duration, sleep quality, and sleep continuity (Emslie et al., 2001). Future 
studies should consider an adaptation night to permit acclimatization to the recording 
equipment during sleep. 
Fifth, through several experimental studies, partial and chronic sleep deprivation 
have been shown to alter the concentration levels of several hormone levels, including 
Cortisol, ghrelin, leptin, and insulin in adults (Spiegel et al., 1999; 2004). In particular, 
because leptin levels are associated with the activation of the SNS, inducing an increase 
in heart rate, blood pressure (Shek, Brands, & Hall, 1998), and sympathetic outflow to 
kidneys and adipose tissue (Haynes, Sivitz, Morgan, Walsh, & Mark, 1997), leptin should 
be examined. Unfortunately, in the present study no hormones were measured. It is 
highly recommended that future studies investigate these physiological changes in 
hormone levels during sleep in youth. 
The sixth limitation was the modest sample size, which due to power limitations 
precluded some of the statistical analyses. Because the BioSomnia sleep recorder is new 
technology, several participants experienced problems associated with correctly operating 
the equipment and we quickly learned gel-based electrodes were needed to adequately 
capture the EEG signals; these technical problems reduced our sample size by about 30%. 
The reduced sample size and inevitably loss of power may explain why frequency-
domain HRV variables could not be used as manifest variables in the SEM model. 
However, the average sample size in standard PSG sleep studies with youth is about 60 
(ranges from 24 to 87; e.g., Beebe et al., 2007; Kirov et al., 2004; O'Brien et al., 2004). 
In addition, because we obtained multiple measures within each participant, the reliability 
and stability of PSG derived variables increased. 
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Lastly, although we statistically controlled for the effects of age (sex and pubertal 
status did not differ), we did not control for other important covariates including food 
intake, physical activity, and duration of obesity. 
Future Directions 
To date, this was the first study that investigated the association between 
autonomic dysfunction, sleep, and obesity in children and adolescents using objectively 
assessed PSG data. Given that autonomic dysfunction, as measured by HRV, did not 
show evidence of partially mediating the association between sleep and obesity, it is 
important to consider how other indicators of autonomic dysfunction may play a role. 
For example, blood pressure typically drops by 10-20% during sleep and this drop is 
referred to as "dipping" (Pickering, 1990). Interestingly, individuals who do not show 
dipping (non-dippers) exhibit less time in SWS (Loredo, Nelesen, Ancoli-Israel, & 
Dimsdale, 2004) and are at greater risk for hypertension, left-ventricular hypertrophy, and 
mortality, independent of 24-hour blood pressure and obstructive sleep apnea (Ohkubo et 
al., 2002; Verdecchia et al., 1990). This suggests another potential autonomic 
dysfunction pathway that should be further investigated. 
Although sleep is linked with multiple physiological changes, (i.e., metabolic, 
endocrine, and cerebral activity) and psychosocial factors (i.e., stress, socio-economic 
status), there is little information available as to the role between sleep and obesity, 
especially within a pediatric population. In future studies it is important to examine other 
metabolic and hormonal profiles (e.g., Cortisol, ghrelin, leptin, insulin, etc.) across 
specific sleep stages (i.e., SWS and REM sleep). Much of this work has been conducted 
in lean healthy young men and results cannot be generalized to children and adolescents. 
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Investigating the metabolic and endocrine functioning across sleep stages in children may 
elucidate other physiologic responses that confer risk for the development and 
maintenance of obesity. 
Conclusion 
Given that obesity is a risk factor for multiple chronic diseases, disability, and 
premature death, better understanding of the pathogenesis of obesity is of great 
importance. While robust data support an association between sleep and obesity, the 
mechanisms underlying their relation are complex and unclear. The present study was 
aimed to develop new knowledge about autonomic dysfunction as one such possible 
mechanism. 
In summary, short sleep duration, poor fragmented sleep quality, more time in 
REM sleep, and less time in SWS were associated with greater adiposity in children and 
adolescents. Similarly, autonomic dysfunction, characterized by reduced HRV and 
parasympathetic activity was associated with greater adiposity in youth. Autonomic 
dysfunction did not directly mediate the relation between sleep and obesity. Future 
research should further examine how autonomic functioning over the course of sleep in 
synchronization with hormonal and endocrine functioning, affect the relation between 
sleep and obesity. 
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Table 1. 
Participant Characteristics (N=\22) 
N(Mean) % (SD) 
Children 
Age (years) (12.81) (2.19) 
Sex 
Female 62 50.8% 
Male 60 49.2% 
Completed Sleep Study with 



































Means and Standard Deviations for Obesit 
Girls 
Mean SD 
Waist (cm) 72.25 10.72 
Hip (cm) 92.17 11.63 
Weight (lbs) 115.82 31.50 
BMI(kg/m2) 21.33 4.66 
Percent Body Fat (%) 26.72 8.51 
BMI Percentile (%ile) 63.03 25.58 
Measures in Youth 
Boys Overall 
Mean SD Mean SD 
74.01 8.16 73.14 9.52 
90.64 9.69 91.42 10.71 
121.83 29.66 118.77 30.63 
20.66 3.13 20.99 3.98 
17.15 8.31 21.97 9.66 
64.85 24.75 63.92 25.09 
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Table 3. 
Self-Report Pubertal Status - Girls 















Have you started to have hair growing in armpits? 
Yes 49 80.3% 
No 12 19.7% 
Missing 1 0.8% 
Have your begun menstrual periods yet? 
Yes 41 66.1% 
No 21 33.9% 
Age of first menstrual (11.99) (1.03) 
period (years) 
Note. N=62. 






























Self-Report Pubertal Status - Boys 



















Have you started to have hair growing in armpits? 
Yes 38 63.3% 
No 22 36.7% 
Note. N=60. 














Has your voice changed? 
No, it's the same 
Yes, occasionally 






















Means and Standard Deviations for Subjective Sleep Measures (n=57) 
Child-Report 
Overall Sleep Quality 
Sleep Study Sleep Quality 
School Sleep Duration 
Weekend Sleep duration 
Daytime Sleepiness 
Parent-Report 
School Sleep Duration 
Weekend Sleep duration 
CSHQ Sleep Disturbance 
CSHQ Bedtime Resistance 
CSHQ Sleep Onset Delay 
CSHQ Sleep Anxiousness 
CSHQ Night Awakenings 
CSHQ Parasomnias 
CSHQ Daytime Sleepiness 




8 h 56 min 
lOh 
14.29 
9 h 07 min 













1 h 13 min 
4.82 
56 min 









Note. CSHQ = Children's Sleep Habits Questionnaire. 
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Table 6. 
Means and Standard Deviations for Objective Sleep Study Measures (n=57) 
Mean SD 
Sleep Period Time (min) 517.03 77.75 
Total Sleep Time (min) 467.28 100.91 
Fragmented Sleep3 50.91 30.22 
Light NREM Time (%)b 23.40 8.17 
Slow Wave Sleep Time (%)c 20.19 8.57 
REM Time (%) 45.07 17.69 
Sleep Efficiency (%)d 89.37 11.39 
Sleep Latency (min) 1.97 2.83 
Intermittent Time Awake 44.87 34.16 
Micro Arousal Index 9.09 6.28 
Sleep Apnea Index 0.05 0.36 
Note. "Number of awakenings lasting at least 15 sec. bStages 1 and 2. cStages 3 and 4. 
Total Sleep Time/Sleep Period Time. 
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Table 7. 
Means and Standard Deviations for HRV Measures during Light NREM, Slow Wave 




































































Note. LF = low frequency (ms2); HF = high frequency (ms2); LFnu = low frequency 
normalized unit; HFnu = high frequency normalized unit; SDNN = standard deviation of 
normal to normal R-R intervals (ms ); rMSSD = root mean square difference among 
successive R-R normal intervals (ms2); pNN50 (%) = percentage of differences between 
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Table 9. 
Inter-correlations among Obesity Measures 
Subscales 1 2 3 4 5 6 
Participants (n=\ 18) 
1. Waist (cm) - .82** .87** .92** .62** .74** 
2. Hip (cm) - .87** .86** .70** .71** 
3. Weight (lbs) - .87** .52** .74** 
4. BMI(kg/m2) - .76** .81** 
5. Percent Body Fat (%) - .64** 
6. BMI Percentile (%ile) 
Note. Partial correlations while controlling for age. **;?<.001 level (2-tailed). 
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Table 10. 
Inter-correlations among Child- and Parent-Report Subjective Sleep Measures. 
1 2 3 4 5 6 7 8 
Participants («=57) 
1. Overall Sleep Quality1 - .26* .28* .00 -.50** .22 -.33* -.30* 
2. Sleep Study Sleep Quality3 - -.18 .00 -.11 .10 .02 -.24* 
3. School Sleep Duration3 - -.08 .25 .35* -.14 .01 
4. Weekend Sleep Duration3 - .05 .13 .32* -.16 
5. Daytime Sleepiness3 - -.06 .31* .33* 
6. School Sleep Duration - .23 -.23 
7. Weekend Sleep Durationb - .19 
8. CSHQ Sleep Disturbanceb 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Inter-correlations among HRVMeasures 
Participants («=57) 
l.LF - .65** .26* .32* -.23 .74** .59** .41** 
2. HF - -.26* -.17 .21 .92** .93** .78** 
3. LF/HF Ratio - .97** -.95** -.30* -.38** -.53** 
4. LFnu - .94** -.22 -.28* -.43** 
5. UFnu - .26* .29* .43** 
6. SDNN - .94** .83* 
7.rMSSD - .91** 
8. pNN50 
Note. LF = low frequency (ms ); HF = high frequency (ms ); LFnu = low frequency 
normalized unit; HFnu = high frequency normalized unit; SDNN = standard deviation of 
normal to normal R-R intervals (ms2); rMSSD = root mean square difference among 
successive R-R normal intervals (ms2); pNN50 (%) = percentage of differences between 
successive R-R intervals that are greater than 50 milliseconds (ms) apart. 
*/?<.05 level (2-tailed). ** p<.001 level (2-tailed). 
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Table 15. 
Partial Correlations between Subjective Sleep Measures and Obesity Measures 
Child-Report 
Overall Sleep Quality 
Sleep Study Sleep Quality 
School Sleep Duration 
Weekend Sleep Duration 
Daytime Sleepiness 
Parent-Report 
School Sleep Duration 
Weekend Sleep Duration 
CSHQ Sleep Disturbance 
CSHQ Bedtime Resistance 
CSHQ Sleep Onset Delay 
CSHQ Sleep Anxiousness 
CSHQ Night Awakenings 
CSHQ Parasomnias 













































































































Note. Partial correlations while controlling for age. CSHQ = Children's Sleep Habits 
Questionnaire.*/?<.05 level (2-tailed). 
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Table 16. 
Partial Correlations between Objective Sleep Measures and Obesity Measures 
Waist Hip Weight BMI Percent BMI 
(cm) (cm) (lbs) (kg/m2) Body percentile 
Fat (%) (%ile) 
Sleep Period Time 
Participants (n = 57) 
-.25 -.16 -.21 -.25 -.05 .17 
Total Sleep Time 
-.15 -.02 -.07 -.14 .03 .16 
Fragmented Sleep3 .29* -.18 -.21 .27s1 .08 .20 
Light NREM(%) Time" -.22 -.21 -.16 -.19 .16 .13 
Slow Wave Sleep (%) Timec -.29* -.27* -.27* -.26* -.27s1 .24 
REM Sleep Time .29* .32* .29* .29" .27* .19 
Sleep Efficiency (%)d .08 .14 .13 .11 .10 .02 
Sleep Latency (min) .02 -.09 -.10 -.06 -.03 -.13 
Intermittent Time Awake .16 -.10 .14 -.14 .05 -.05 
Micro Arousal Index .07 .13 .08 .07 .16 .12 
Note. Partial correlations while controlling for age. "Number of awakenings lasting at 
least 15 sec. bStages 1 and 2. cStages 3 and 4. dTotal Sleep Time/Sleep Period Time. 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Participants (n = 57) 
-.30* -.28* -.34* -.32" .37" 
HF -.30" .33* -.32" -.34" -.28" -.32" 
LF/HF Ratio -.03 .04 .05 .03 -.06 -.07 
LFnu .02 .02 .02 .08 .12 .13 
HFnu .02 .04 -.08 .04 .09 .12 
SDNN -.33* -.32" -.28" -.36" -.33* -.34" 
rMSSD -.33* -.33* -.30" -.34* .29" .34" 
pNN50 -.29" -.27" -.28" -.26" -.13* -.25* 
Note. Partial correlations while controlling for age. LF = low frequency (ms ); HF = high 
frequency (ms ); LFnu = low frequency normalized unit; HFnu = high frequency 
normalized unit; SDNN = standard deviation of normal to normal R-R intervals (ms2); 
rMSSD = root mean square difference among successive R-R normal intervals (ms ); 
pNN50 (%) = percentage of differences between successive R-R intervals that are greater 
than 50 milliseconds (ms) apart. */?<.05 level (2-tailed). 
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Table 21. 
















Participants {n = 57) 
LF -.21 .27* .18 .29" .41 = -.31* 
HF .31* .34* .32" .35" .32" .31* 
LF/HF Ratio .06 .05 .12 -.03 -.18 .11 
LFnu -.01 .02 .05 -.09 -.23 .18 
HFnu -.09 -.10 .18 -.03 .14 .14 
SDNN .37" .39" -.35" -.40" .39" .36" 
rMSSD .36" .35" .34" -.36" .29" -.34" 
pNN50 .32" -.33" -.32" -.29" .19 .26* 
Note. Partial correlations while controlling for age. LF = low frequency (ms2); HF = high 
frequency (ms2); LFnu = low frequency normalized unit; HFnu = high frequency 
normalized unit; SDNN = standard deviation of normal to normal R-R intervals (ms2); 
rMSSD = root mean square difference among successive R-R normal intervals (ms ); 
pNN50 (%) = percentage of differences between successive R-R intervals that are greater 
than 50 milliseconds (ms) apart. *p<.05 level (2-tailed). 
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Table 22. 
Partial Correlations between Obesity Measures and HRV Measures during REM Sleep 
Waist 
(cm) 
Hip Weight BMI Percent BMI 
(cm) (lbs) (kg/m2) Body Fat percentile 
(%ile) 
LF .31' 
Participants (n - 57) 
-.31* -.28* -.34* .34s1 -.37s1 
HF - .27* .30" .27* -.31' .28* -.28* 
LF/HF Ratio .04 .06 .08 .01 .06 -.14 
LFnu -.01 .01 .04 .06 -.11 -.20 
HFnu .01 -.05 -.07 .03 .07 .19 
SDNN - .34* .37" .31* .38" .37" -.36" 
rMSSD -.31" .32" -.28" -.32" -.28" -.29" 
pNN50 -.25* -.31* -.25" -.25* -.22 -.19 
Note. Partial correlations while controlling for age. LF = low frequency (ms ); HF = high 
frequency (ms2); LFnu = low frequency normalized unit; HFnu = high frequency 
normalized unit; SDNN = standard deviation of normal to normal R-R intervals (ms2); 
rMSSD = root mean square difference among successive R-R normal intervals (ms2); 
pNN50 (%) = percentage of differences between successive R-R intervals that are greater 
than 50 milliseconds (ms) apart. *p<05 level (2-tailed). 
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